{"meta":{"query_hash":"454ddb1c1797","filters":{"venue":"Neurology Neuroimmunology & Neuroinflammation"},"cohort_total":68,"direct_labels_cover":0,"predictions_cover":68,"exported":68,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/454ddb1c1797","api":"https://metacan.xera.ac/api/v1/cohort?venue=Neurology+Neuroimmunology+%26+Neuroinflammation"},"results":[{"id":"W2123878928","doi":"10.1212/nxi.0000000000000035","title":"Transient neonatal autoimmune autonomic ganglionopathy","year":2014,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Autonomic nervous system; Neuroscience; Pure autonomic failure; Acetylcholine; Acetylcholine receptor; Autonomic ganglion; Nicotinic agonist; Medicine; Immunology; Receptor; Biology; Endocrinology; Internal medicine; Heart rate; Blood pressure","score_opus":0.00809733013863895,"score_gpt":0.21928991356482383,"score_spread":0.21119258342618488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123878928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788087,0.00028803202,0.00077478733,0.01337668,0.0012002506,0.00093446655,0.0000062353174,0.0008312448,0.0037796032],"genre_scores_gemma":[0.992762,0.00017345324,0.00010793072,0.0061582867,0.00010962258,0.00009417437,0.0001260795,0.000108557724,0.0003598559],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960658,0.0006545065,0.0009441596,0.0011559727,0.0003007092,0.00087884354],"domain_scores_gemma":[0.9978744,0.00034743347,0.00036357154,0.001136463,0.0001159321,0.00016221523],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024354456,0.0006015715,0.00089356484,0.00044405193,0.000370729,0.000040521423,0.00036786209,0.00048472127,0.00025104062],"category_scores_gemma":[0.00038107048,0.00056124025,0.00037172413,0.00039472998,0.0005090075,0.00023760305,0.00017256329,0.0011829215,0.0007743344],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009650286,0.0023592035,0.05902881,0.00015262527,0.00048271797,0.0037025905,0.0007435054,0.002282382,0.7145535,0.0118434895,0.001097076,0.19410384],"study_design_scores_gemma":[0.0052216444,0.005623724,0.9330226,0.0000115029,0.00019644418,0.002687763,0.0000059762347,0.007057615,0.0019928508,0.00082202395,0.043005165,0.000352647],"about_ca_topic_score_codex":0.00002055776,"about_ca_topic_score_gemma":0.0000050586323,"teacher_disagreement_score":0.8739938,"about_ca_system_score_codex":0.000034440618,"about_ca_system_score_gemma":0.000093370036,"threshold_uncertainty_score":0.9996839},"labels":[],"label_agreement":null},{"id":"W2198811857","doi":"10.1212/nxi.0000000000000104","title":"B lymphocytes in neuromyelitis optica","year":2015,"lang":"en","type":"review","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"National Eye Institute; Chugai Pharmaceutical; Novartis Pharma; Genentech; Multiple Sclerosis Society; Myelin Repair Foundation; National Institutes of Health; Guthy-Jackson Charitable Foundation; Questcor Pharmaceuticals; Biogen; U.S. Department of Defense; Sanofi; Pfizer; Eli Lilly and Company; Myasthenia Gravis Foundation of America; Deutsche Forschungsgemeinschaft; National Multiple Sclerosis Society; National Institute of Neurological Disorders and Stroke; Teva Pharmaceutical Industries; U.S. Department of Veterans Affairs; Alnylam Pharmaceuticals","keywords":"Neuromyelitis optica; Autoantibody; Immunology; Aquaporin 4; Astrocyte; Pathogenesis; B cell; Proinflammatory cytokine; Autoimmunity; Medicine; Autoimmune disease; Inflammation; Biology; Neuroscience; Antibody; Pathology; Central nervous system","score_opus":0.10842968246215468,"score_gpt":0.38110926550645097,"score_spread":0.2726795830442963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2198811857","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007849172,0.98134977,0.0000018920192,0.0021442035,0.0013074413,0.0037786546,0.000055375578,0.00046996883,0.0030435415],"genre_scores_gemma":[0.00029610906,0.99723333,0.000053215776,0.00048804743,0.0003808778,0.0006260238,0.00036004596,0.00028489417,0.0002774621],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912257,0.002424046,0.0021678905,0.0019338602,0.00074605324,0.0015024442],"domain_scores_gemma":[0.9951851,0.0015036187,0.0007982848,0.0018392828,0.00035245542,0.0003213079],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006278138,0.0012905302,0.004724367,0.0021578548,0.00017286807,0.000060108865,0.0008161672,0.0012909657,0.00011074215],"category_scores_gemma":[0.00330863,0.0011526487,0.0007658023,0.001417912,0.00084878906,0.00025704518,0.000881955,0.003506347,0.0010471842],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005266595,0.000240615,0.00016210772,0.004607321,0.00018015779,0.0039003682,0.00007225181,0.000012176083,0.00022208737,0.00012339279,0.0008606191,0.98909223],"study_design_scores_gemma":[0.0025761004,0.0016977249,0.012532847,0.001315335,0.0005152628,0.0049736556,0.0000045978045,0.00015902314,0.000008343121,0.000050590603,0.97561425,0.0005522833],"about_ca_topic_score_codex":0.00004231128,"about_ca_topic_score_gemma":0.000027242433,"teacher_disagreement_score":0.98853993,"about_ca_system_score_codex":0.00029965612,"about_ca_system_score_gemma":0.001346902,"threshold_uncertainty_score":0.9999846},"labels":[],"label_agreement":null},{"id":"W2282937261","doi":"10.1212/nxi.0000000000000206","title":"Degos disease mimicking primary vasculitis of the CNS","year":2016,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Children's Hospital of Philadelphia; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Biogen; Multiple Sclerosis Scientific Research Foundation; Teva Pharmaceutical Industries; Eli Lilly and Company; Sanofi; University of Oxford; National Multiple Sclerosis Society","keywords":"Medicine; Vasculitis; Headaches; Hemiparesis; Radiology; Magnetic resonance imaging; Magnetic resonance angiography; Angiography; Circle of Willis; Pathology; Disease; Surgery","score_opus":0.014279688206939277,"score_gpt":0.22892096354507785,"score_spread":0.21464127533813857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282937261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96979696,0.00019705339,0.0001385622,0.025745997,0.0012744642,0.000671725,0.000012673821,0.00020788917,0.0019546591],"genre_scores_gemma":[0.99590945,0.00042634507,0.000019029898,0.0030337991,0.00012749046,0.000055859815,0.0000047285985,0.000049257244,0.000374052],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99748045,0.0005746146,0.00065643335,0.00054968835,0.0003050181,0.00043376876],"domain_scores_gemma":[0.9976552,0.0005951647,0.00043502578,0.0010241205,0.00020155554,0.00008889668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017936522,0.00028791683,0.00049169676,0.00024317937,0.00023550849,0.0000072951784,0.00028103497,0.00016749378,0.0001137495],"category_scores_gemma":[0.0011892716,0.00018217502,0.00030895203,0.00034732392,0.0008677326,0.00019154005,0.0003137912,0.00043802874,0.0002277234],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091525464,0.00012390653,0.25612038,0.000062697225,0.00009904405,0.00011674546,0.000059695918,0.000015926991,0.7321807,0.0007949661,0.00085429376,0.008656339],"study_design_scores_gemma":[0.0019584962,0.00023889345,0.97049,0.000040178784,0.00018842648,0.0005662625,0.0000018952596,0.000021531312,0.013889573,0.0002952267,0.012179307,0.0001302589],"about_ca_topic_score_codex":0.000007802059,"about_ca_topic_score_gemma":0.000005042305,"teacher_disagreement_score":0.71829116,"about_ca_system_score_codex":0.000040275994,"about_ca_system_score_gemma":0.000162015,"threshold_uncertainty_score":0.74288815},"labels":[],"label_agreement":null},{"id":"W2509787928","doi":"10.1212/nxi.0000000000000277","title":"Restoring immune tolerance in neuromyelitis optica","year":2016,"lang":"en","type":"review","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Guthy-Jackson Charitable Foundation","keywords":"Neuromyelitis optica; Neuroscience; Immune system; Immunology; Medicine; Disease; Immune tolerance; Aquaporin 4; Bioinformatics; Biology; Multiple sclerosis; Pathology","score_opus":0.024126786713647812,"score_gpt":0.27792626443029284,"score_spread":0.253799477716645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509787928","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010839723,0.9769846,0.000017882241,0.00084441627,0.007690737,0.0020423012,0.0000690099,0.00057371723,0.00093759166],"genre_scores_gemma":[0.0015564095,0.9942233,0.000011857657,0.0002706173,0.00019839102,0.0005686286,0.00023721824,0.00038087805,0.0025527203],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9859184,0.006124311,0.0034042483,0.002264338,0.00017719885,0.0021115253],"domain_scores_gemma":[0.9919595,0.0033134657,0.0017558119,0.00277665,0.00013794802,0.000056635694],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0008982279,0.0018443571,0.00447971,0.0021209572,0.000507576,0.00007906236,0.002094835,0.002661861,0.0006743382],"category_scores_gemma":[0.0011578532,0.0015711967,0.0011804682,0.0010703417,0.0011890165,0.00057291484,0.00069069525,0.0043476406,0.004805478],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011764915,0.00022933824,0.000030190718,0.0013569532,0.0003188351,0.0009496096,0.00012800256,0.000011087883,0.040465925,0.001089154,0.00023836023,0.9540061],"study_design_scores_gemma":[0.0024516494,0.001048141,0.00235728,0.0029485433,0.0002156353,0.0045768726,0.0000039224115,0.0000025664422,0.00057375705,0.00010891377,0.9846129,0.0010998234],"about_ca_topic_score_codex":0.00005142769,"about_ca_topic_score_gemma":0.000010880078,"teacher_disagreement_score":0.9843745,"about_ca_system_score_codex":0.0001662178,"about_ca_system_score_gemma":0.0005414066,"threshold_uncertainty_score":0.9994301},"labels":[],"label_agreement":null},{"id":"W2597919924","doi":"10.1212/nxi.0000000000000340","title":"Dimethyl fumarate–induced lymphopenia in MS due to differential T-cell subset apoptosis","year":2017,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"McGill University","keywords":"Apoptosis; CD8; In vivo; T cell; Cell; Programmed cell death; In vitro; Cytotoxic T cell; Biology; Immunology; Chemistry; Molecular biology; Cell biology; Immune system; Biochemistry; Genetics","score_opus":0.0382436734497531,"score_gpt":0.30568102827431387,"score_spread":0.26743735482456077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597919924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731847,0.000027417782,0.000020216536,0.021002404,0.0014326423,0.0017674943,0.000018646677,0.00018077297,0.002365695],"genre_scores_gemma":[0.99749506,0.00026730646,0.000052091003,0.0012638076,0.00022702239,0.00025588478,0.000038294682,0.00010103755,0.00029949468],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9952634,0.00081073213,0.0009113016,0.001315675,0.00050637923,0.0011925219],"domain_scores_gemma":[0.99642247,0.00047555595,0.00047489302,0.0021382235,0.00022929836,0.00025957276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003433229,0.0005776759,0.0011060088,0.0008408764,0.00077964726,0.00014832789,0.0009951713,0.00044831636,0.00024414796],"category_scores_gemma":[0.0024466722,0.0005726621,0.00021576288,0.0003133348,0.00045576275,0.0003964202,0.0010475405,0.0012956737,0.00056236226],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028225738,0.00030303057,0.02897921,0.000052352058,0.00004798876,0.00048992794,0.00020834096,0.000021487554,0.9572793,0.000042654246,0.00053898984,0.009214118],"study_design_scores_gemma":[0.0048470516,0.0016505088,0.85069394,0.000023209886,0.000053102845,0.00018427447,0.000008545362,0.0006477576,0.14023365,0.0000357224,0.001332221,0.00029000908],"about_ca_topic_score_codex":0.0003743824,"about_ca_topic_score_gemma":0.00028428997,"teacher_disagreement_score":0.82171476,"about_ca_system_score_codex":0.00008072864,"about_ca_system_score_gemma":0.00014989283,"threshold_uncertainty_score":0.9996725},"labels":[],"label_agreement":null},{"id":"W2766659089","doi":"10.1212/nxi.0000000000000402","title":"MerTK-mediated regulation of myelin phagocytosis by macrophages generated from patients with MS","year":2017,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"MERTK; Phagocytosis; Flow cytometry; Myelin; Microglia; Biology; Cell biology; Immunology; Receptor tyrosine kinase; Inflammation; Kinase; Endocrinology; Central nervous system","score_opus":0.007338399895011123,"score_gpt":0.20197246765468818,"score_spread":0.19463406775967707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766659089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946962,0.0007278673,0.00011674525,0.0017618684,0.0012529388,0.0007352585,0.0002573646,0.00019102244,0.00026073365],"genre_scores_gemma":[0.99617475,0.00021203529,0.00003806221,0.0003088457,0.000048472368,0.000049068592,0.0028573298,0.00008790235,0.00022352382],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99625415,0.0009165084,0.0010429486,0.0009730718,0.00016772897,0.00064557575],"domain_scores_gemma":[0.9956473,0.00041889958,0.0018335668,0.0016390869,0.00041816646,0.000042982367],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020949019,0.0005533334,0.00083181384,0.0002916242,0.0009073399,0.00007251403,0.0009106593,0.0007155167,0.00048030933],"category_scores_gemma":[0.0004932652,0.000507483,0.00015236696,0.00018625477,0.0011278847,0.0007525383,0.0002719296,0.0007386596,0.00027635606],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001859143,0.000272215,0.056693792,0.000010573328,0.00022455398,0.000006616825,0.0000705609,0.000066671404,0.93477166,0.000072388204,0.0011761034,0.0047757206],"study_design_scores_gemma":[0.0042218645,0.00087637344,0.6514594,0.000013507681,0.00011030701,0.00001558404,0.000002357881,0.00017362775,0.33898887,0.00006516292,0.0038198694,0.0002530923],"about_ca_topic_score_codex":0.00034802887,"about_ca_topic_score_gemma":0.00004044489,"teacher_disagreement_score":0.5957828,"about_ca_system_score_codex":0.000029277115,"about_ca_system_score_gemma":0.00007161247,"threshold_uncertainty_score":0.9997377},"labels":[],"label_agreement":null},{"id":"W2780348759","doi":"10.1212/nxi.0000000000000432","title":"Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimod","year":2017,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Dimethyl fumarate; Fingolimod; Flow cytometry; Lymphocyte; Immunology; Molecular biology; Chemistry; Medicine; Multiple sclerosis; Biology","score_opus":0.013191553727789532,"score_gpt":0.24046685271144042,"score_spread":0.2272752989836509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2780348759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966096,0.000009608374,0.000006904261,0.0019453866,0.000057570378,0.0010741787,0.000013875444,0.000048715654,0.00023412643],"genre_scores_gemma":[0.9993744,0.00020086988,0.000034045268,0.00015668389,0.000019654057,0.000052816104,0.00008166439,0.00004364591,0.00003622127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981164,0.0002674637,0.00041832865,0.00055768434,0.00025382542,0.0003863487],"domain_scores_gemma":[0.99822587,0.00013524588,0.0005347575,0.0007866313,0.00025467976,0.00006278942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012449651,0.00027525975,0.00057916803,0.0003607749,0.00025648158,0.00003445278,0.0002074,0.00015350722,0.0000147394],"category_scores_gemma":[0.0003924338,0.00021382366,0.000031213895,0.00016040627,0.0007774965,0.00037989396,0.00018758829,0.00040024795,0.0000068384315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005891972,0.00013545294,0.6763702,0.000039492577,0.00004317113,0.000054022876,0.00007271124,0.0000067127944,0.31300163,0.000015879417,0.0000011317562,0.0043676295],"study_design_scores_gemma":[0.008506317,0.0036081166,0.97641814,0.000047162557,0.000053111755,0.00005090396,0.0000016422786,0.0003154815,0.010784534,0.000003839477,0.00007917296,0.00013157194],"about_ca_topic_score_codex":0.00011457281,"about_ca_topic_score_gemma":0.000087801534,"teacher_disagreement_score":0.3022171,"about_ca_system_score_codex":0.000018263892,"about_ca_system_score_gemma":0.000058011665,"threshold_uncertainty_score":0.8719475},"labels":[],"label_agreement":null},{"id":"W2783237032","doi":"10.1212/nxi.0000000000000436","title":"Quantitative spinal cord MRI in radiologically isolated syndrome","year":2018,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Oryzon Genomics; Teva Pharmaceutical Industries; Biogen; Sanofi; EMD Serono; National Multiple Sclerosis Society","keywords":"Medicine; Fractional anisotropy; Diffusion MRI; Spinal cord; Magnetic resonance imaging; White matter; Atrophy; Magnetization transfer; Nuclear medicine; Radiology; Internal medicine","score_opus":0.050883451435789914,"score_gpt":0.3403414783980208,"score_spread":0.2894580269622309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783237032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743635,0.00017216471,0.00013532494,0.021906612,0.0006989638,0.0011888342,0.0000067205287,0.0003110668,0.0012167834],"genre_scores_gemma":[0.9958381,0.001425345,0.0003055963,0.0020430568,0.00011112726,0.000096321564,0.000032551758,0.000057848014,0.00009003682],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99565876,0.0010503505,0.00090316526,0.0010713683,0.00033947194,0.0009768655],"domain_scores_gemma":[0.99790967,0.0005404625,0.00029645936,0.0007535464,0.00036643367,0.00013342465],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040524345,0.00043162282,0.00085413153,0.00081554113,0.00027163385,0.000025061756,0.00038941237,0.00040997262,0.0002161385],"category_scores_gemma":[0.0016743857,0.00040118836,0.0001494255,0.00087293395,0.0016395343,0.00024091541,0.00032086135,0.0014917933,0.00069808273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06897215,0.0006320371,0.056299917,0.00009566814,0.00021380858,0.004938753,0.00028850313,0.000038363632,0.8500377,0.0014297131,0.0014597075,0.015593713],"study_design_scores_gemma":[0.0028673739,0.048522793,0.93784827,0.000036127636,0.00003617211,0.002893735,0.000017943355,0.0033788693,0.00080321665,0.00019737249,0.003170009,0.00022813938],"about_ca_topic_score_codex":0.000036720776,"about_ca_topic_score_gemma":0.00007002573,"teacher_disagreement_score":0.88154835,"about_ca_system_score_codex":0.00005543192,"about_ca_system_score_gemma":0.000113453054,"threshold_uncertainty_score":0.999844},"labels":[],"label_agreement":null},{"id":"W2891878956","doi":"10.1212/nxi.0000000000000499","title":"Physical activity and dentate gyrus volume in pediatric acquired demyelinating syndromes","year":2018,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Ontario Brain Institute; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Interquartile range; Medicine; Dentate gyrus; White matter; Internal medicine; Hippocampus; Magnetic resonance imaging; Radiology","score_opus":0.030782241289427702,"score_gpt":0.31075791559167804,"score_spread":0.27997567430225034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891878956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99063045,0.00007821981,0.00001314051,0.0075438176,0.00038435915,0.00077571615,0.0000044623107,0.00019976559,0.0003700919],"genre_scores_gemma":[0.9981771,0.0007501884,0.000048549548,0.00037538947,0.00040484298,0.000071389564,0.000007989104,0.00005406802,0.000110497014],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969614,0.00067315,0.00041005874,0.00088365196,0.00031600098,0.00075571385],"domain_scores_gemma":[0.9984164,0.00056893175,0.00023345352,0.00049093075,0.00017540829,0.00011488132],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002553532,0.0003489848,0.0006318171,0.00063417223,0.00028624982,0.000030923777,0.00020514688,0.00021487537,0.00003138322],"category_scores_gemma":[0.0015029834,0.00035072246,0.00009287077,0.0005831916,0.0008398238,0.00032619017,0.00043864944,0.0007476068,0.00015456155],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016971861,0.00036115723,0.4568042,0.000111503556,0.000044750203,0.00055274245,0.00058225397,0.000014496516,0.49456564,0.00005423853,0.000115551586,0.045096293],"study_design_scores_gemma":[0.0022437202,0.002089046,0.97821426,0.0000100719835,0.00006392383,0.0006850003,0.000010876562,0.010794938,0.005415387,0.00007245355,0.00022123933,0.00017909927],"about_ca_topic_score_codex":0.000051341314,"about_ca_topic_score_gemma":0.0000732846,"teacher_disagreement_score":0.52141005,"about_ca_system_score_codex":0.0000359668,"about_ca_system_score_gemma":0.00007689271,"threshold_uncertainty_score":0.9998945},"labels":[],"label_agreement":null},{"id":"W2895793418","doi":"10.1212/nxi.0000000000000516","title":"Case of alemtuzumab-related alopecia areata management in MS","year":2018,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Alemtuzumab; Medicine; Alopecia areata; Multiple sclerosis; Dermatology; Surgery; Internal medicine; Gastroenterology; Immunology","score_opus":0.011977028436390893,"score_gpt":0.25552710117490834,"score_spread":0.24355007273851745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895793418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775848,0.00008402444,0.00003127623,0.002987533,0.0006206706,0.000851654,0.000004322679,0.00014786165,0.017687857],"genre_scores_gemma":[0.9980379,0.00014340365,0.00008309581,0.0013503153,0.000059286365,0.00003359782,0.00003761565,0.0000496425,0.0002051513],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973931,0.0003498403,0.0008868948,0.00066741236,0.0001638299,0.0005389753],"domain_scores_gemma":[0.9985517,0.0001502995,0.00025808898,0.00082025834,0.00013210633,0.00008749969],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021376708,0.00029950964,0.0005217808,0.00081714644,0.00010812833,0.0000084006915,0.00021349583,0.00030429038,0.00027320383],"category_scores_gemma":[0.00021706504,0.0003111677,0.000117531905,0.00071955094,0.0006767691,0.00015901159,0.00016480201,0.00059215043,0.00023187541],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017259356,0.0029141319,0.21038625,0.00080285355,0.0008775497,0.19901846,0.0035719918,0.00044537697,0.36560982,0.02834442,0.0034090963,0.1673607],"study_design_scores_gemma":[0.009684459,0.0050811623,0.9266811,0.000040305753,0.00024342316,0.03901884,0.000095644704,0.002891943,0.0065559517,0.0015142412,0.0078079896,0.00038494964],"about_ca_topic_score_codex":0.000061335544,"about_ca_topic_score_gemma":0.00016271851,"teacher_disagreement_score":0.7162948,"about_ca_system_score_codex":0.000021319087,"about_ca_system_score_gemma":0.000061298684,"threshold_uncertainty_score":0.999934},"labels":[],"label_agreement":null},{"id":"W2945729689","doi":"10.1212/nxi.0000000000000576","title":"Age matters","year":2019,"lang":"en","type":"review","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; CSF pleocytosis; Lumbar puncture; Confidence interval; Pleocytosis; Etiology; Pediatrics; Lumbar; Retrospective cohort study; Receiver operating characteristic; Internal medicine; Cerebrospinal fluid; Gastroenterology; Surgery","score_opus":0.04148222317102074,"score_gpt":0.3058954736056806,"score_spread":0.26441325043465985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945729689","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027754952,0.98370063,0.000007760509,0.003187224,0.0042637046,0.002884767,0.000025685187,0.00066038687,0.002494338],"genre_scores_gemma":[0.000055101504,0.9875768,0.000025373449,0.009628343,0.00026010224,0.00015294661,0.00038288767,0.0003450867,0.0015733755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99441046,0.0010510487,0.0015084184,0.001653262,0.00036597604,0.0010108266],"domain_scores_gemma":[0.99645114,0.0005037482,0.00091486,0.0018669971,0.00008914036,0.0001741018],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016821672,0.0011737957,0.003617995,0.00088579033,0.00018340914,0.0000645757,0.0006179461,0.0012446875,0.00026718463],"category_scores_gemma":[0.00025548355,0.0010690333,0.0012586183,0.0006445052,0.00046831282,0.00019027335,0.00037712578,0.0029147598,0.0023951996],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005305772,0.00025942232,0.00004168122,0.01524763,0.00032316128,0.0075992397,0.0000402566,0.000008919024,0.0009631094,0.00028908518,0.013704948,0.960992],"study_design_scores_gemma":[0.0011320236,0.0016290274,0.0004196616,0.00075107854,0.0015318394,0.0055575264,0.0000022065913,0.0000346006,0.0000034785744,0.000034202236,0.9883539,0.00055047066],"about_ca_topic_score_codex":0.000011825235,"about_ca_topic_score_gemma":0.000008510921,"teacher_disagreement_score":0.97464895,"about_ca_system_score_codex":0.000053249798,"about_ca_system_score_gemma":0.00035364422,"threshold_uncertainty_score":0.99938554},"labels":[],"label_agreement":null},{"id":"W2954887335","doi":"10.1212/nxi.0000000000000590","title":"Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP","year":2019,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Japan Society for the Promotion of Science; Sanofi Genzyme; Novartis Pharma; Grifols; Ono Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Teijin Pharma; Bayer Yakuhin; Celgene; Ministry of Education, Culture, Sports, Science and Technology; Pfizer Japan; Shionogi; Argenx; Ministry of Health, Labour and Welfare; Eisai; Japan Blood Products Organization; Boehringer Ingelheim Japan; Kissei; Neurocrine Biosciences; Pfizer; Biogen; Alnylam Pharmaceuticals; Alexion Pharmaceuticals; Heinrich-Heine-Universität Düsseldorf; Bristol-Myers Squibb; GBS/CIDP Foundation International; Teva Pharmaceutical Industries; Myasthenia Gravis Foundation of America; Bayer HealthCare; Kowa Company; Sanofi; CSL Behring","keywords":"Medicine; Chronic inflammatory demyelinating polyneuropathy; Adverse effect; Internal medicine; Polyradiculoneuropathy; Gastroenterology; Surgery; Antibody; Pediatrics; Immunology","score_opus":0.00639744829432481,"score_gpt":0.22983941409222605,"score_spread":0.22344196579790124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954887335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938254,0.00055842183,0.000010016357,0.0025615096,0.0007157595,0.0011141042,0.000004892162,0.00012160415,0.0010883214],"genre_scores_gemma":[0.9971622,0.0012778484,0.000023443072,0.001191596,0.00003303967,0.000009966067,0.000034172317,0.0000610077,0.0002067082],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997179,0.00039965866,0.000921617,0.0007620053,0.00021279682,0.00052492734],"domain_scores_gemma":[0.998341,0.00039977863,0.0003461457,0.00074835797,0.00008567863,0.00007902735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017607388,0.00036197447,0.0007970907,0.00040161563,0.000068395115,0.000013581678,0.00022176959,0.0003214311,0.00015640845],"category_scores_gemma":[0.00028402673,0.00036877842,0.000136614,0.00038631144,0.00037892215,0.0001621009,0.00019429505,0.0008898593,0.00007256527],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014469745,0.00034173686,0.47117773,0.00018550204,0.00003966199,0.0017099424,0.00018218588,0.00024492937,0.49756435,0.00035349172,0.000018502531,0.013712232],"study_design_scores_gemma":[0.006331578,0.0041412525,0.98337936,0.000037735124,0.00005146522,0.0032277496,0.000009407061,0.0005141117,0.0015269349,0.000047305715,0.0005260398,0.0002070454],"about_ca_topic_score_codex":0.000037184942,"about_ca_topic_score_gemma":0.000051838364,"teacher_disagreement_score":0.5122016,"about_ca_system_score_codex":0.000019339079,"about_ca_system_score_gemma":0.00007962333,"threshold_uncertainty_score":0.99987644},"labels":[],"label_agreement":null},{"id":"W2968015278","doi":"10.1212/nxi.0000000000000598","title":"High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS","year":2019,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Montreal Neurological Institute and Hospital","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Medicine; Internal medicine; Hematopoietic stem cell transplantation; Biomarker; Transplantation; Gastroenterology; Expanded Disability Status Scale; Oncology; Multiple sclerosis; Pathology; Immunology","score_opus":0.012009847363095776,"score_gpt":0.24055037982645155,"score_spread":0.2285405324633558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968015278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97637576,0.00017425534,0.00011845096,0.017340882,0.0015252217,0.0035886185,0.000057631667,0.00032874552,0.0004904368],"genre_scores_gemma":[0.9942978,0.00093321793,0.000104444734,0.0028082947,0.000180636,0.0006568117,0.00011543133,0.00013264803,0.0007707226],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99584144,0.0005544441,0.00093928224,0.0011589136,0.0004846498,0.0010212505],"domain_scores_gemma":[0.9976163,0.00063532166,0.00036688495,0.0009662411,0.00026221128,0.00015306435],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002880837,0.0005676806,0.00086755026,0.00052808167,0.00022846025,0.00004636008,0.0003293612,0.00037041723,0.0002489237],"category_scores_gemma":[0.00007667011,0.0005457253,0.0003052554,0.00033357574,0.0002089353,0.00031319857,0.00015948882,0.0008720268,0.00047391283],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01005785,0.00038573387,0.029763859,0.0013006693,0.00012713733,0.0004666406,0.0009673997,0.00038981377,0.9491245,0.0004474888,0.00045661497,0.0065122913],"study_design_scores_gemma":[0.00685213,0.00462122,0.8714186,0.000048082493,0.00020346144,0.00058835134,0.000038027392,0.0012027038,0.107890405,0.0000671068,0.006671454,0.00039848613],"about_ca_topic_score_codex":0.000013995562,"about_ca_topic_score_gemma":0.00001583471,"teacher_disagreement_score":0.8416547,"about_ca_system_score_codex":0.000043594817,"about_ca_system_score_gemma":0.00009455387,"threshold_uncertainty_score":0.9996994},"labels":[],"label_agreement":null},{"id":"W2999177463","doi":"10.1212/nxi.0000000000000663","title":"Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient","year":2020,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":344,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital","funders":"","keywords":"Medicine; Autoimmune encephalitis; Differential diagnosis; Pediatrics; Pediatric hospital; Encephalitis; Autoantibody; Intensive care medicine; Immunology; Antibody; Pathology","score_opus":0.04274760192593441,"score_gpt":0.2845408300582367,"score_spread":0.2417932281323023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999177463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93253565,0.0005033646,0.000055946326,0.06358114,0.00035319204,0.0018332634,0.00000736533,0.000087423796,0.0010426501],"genre_scores_gemma":[0.970754,0.0009076647,0.000054421445,0.027788697,0.00010028774,0.0003236313,0.000026149448,0.000035264427,0.000009848941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99519765,0.0018266554,0.0013067662,0.0007897007,0.00037861755,0.0005006031],"domain_scores_gemma":[0.99743134,0.0010957704,0.00043710318,0.00085557665,0.00009086659,0.00008931779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038965308,0.0003420215,0.00072553294,0.00016522832,0.00016608815,0.00001900288,0.0006727006,0.00027311186,0.000031371233],"category_scores_gemma":[0.0014493841,0.00020907968,0.00029386708,0.0010237524,0.0003378872,0.00009152956,0.00027953828,0.0013154945,0.0000951488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025025574,0.0024608218,0.9580095,0.0000842134,0.00009028835,0.0007097264,0.002674236,0.0013042418,0.0024829945,0.0013957679,0.0014965301,0.02678912],"study_design_scores_gemma":[0.00169161,0.0064543732,0.98225963,0.0000036989632,0.00014612223,0.00030772755,0.000060820126,0.0008776092,0.00006795329,0.000081113365,0.007923059,0.00012630827],"about_ca_topic_score_codex":0.000024832016,"about_ca_topic_score_gemma":0.0000024500432,"teacher_disagreement_score":0.03821838,"about_ca_system_score_codex":0.000007639421,"about_ca_system_score_gemma":0.00007132541,"threshold_uncertainty_score":0.8526022},"labels":[],"label_agreement":null},{"id":"W3028214894","doi":"10.1212/nxi.0000000000000745","title":"Oligodendrocyte ARNT2 expression is altered in models of MS","year":2020,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"OLIG2; Gene knockdown; Viability assay; Molecular biology; Biology; Cell culture; Experimental autoimmune encephalomyelitis; Oligodendrocyte; Cell biology; Cell; Multiple sclerosis; Biochemistry; Immunology; Endocrinology; Myelin; Central nervous system","score_opus":0.05659512577816669,"score_gpt":0.24243029882230593,"score_spread":0.18583517304413924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028214894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99102956,0.000047567464,0.00068702246,0.0054981043,0.0008884817,0.00072898174,0.00002983491,0.00028603862,0.00080443494],"genre_scores_gemma":[0.9856381,0.00040831877,0.000058910886,0.013593299,0.00011711289,0.00004547666,0.0000053617587,0.00011184936,0.000021584121],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9943359,0.0013748634,0.0013142824,0.0016455037,0.0005127129,0.0008167576],"domain_scores_gemma":[0.99739015,0.00083456724,0.0007126884,0.00079778687,0.0000758134,0.00018898086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015066535,0.0005615845,0.0008247353,0.00049293647,0.00016912371,0.00003725476,0.0009978486,0.00034202324,0.00013042896],"category_scores_gemma":[0.0008716884,0.00059899414,0.00022014685,0.00090124685,0.00035385764,0.00064097863,0.0005039104,0.001118191,0.00016712474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001360531,0.00014491414,0.00026365678,0.000048118123,0.000003918283,0.00040860457,0.00040600714,0.0031774072,0.9911272,0.0025802893,0.00016231238,0.0003170282],"study_design_scores_gemma":[0.0017199997,0.001720528,0.0042274175,0.00001576022,0.000020121495,0.0003264109,0.0000058273313,0.032007966,0.9580451,0.0007227636,0.0008694257,0.00031863013],"about_ca_topic_score_codex":0.000008264255,"about_ca_topic_score_gemma":0.0000032221024,"teacher_disagreement_score":0.033082064,"about_ca_system_score_codex":0.000013145373,"about_ca_system_score_gemma":0.00008075988,"threshold_uncertainty_score":0.9996461},"labels":[],"label_agreement":null},{"id":"W3033743882","doi":"10.1212/nxi.0000000000000765","title":"Serum antibodies to phosphatidylcholine in MS","year":2020,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; University of California, San Francisco; National Institutes of Health; Deutsche Forschungsgemeinschaft; Banco Santander; Mallinckrodt Pharmaceuticals; National Multiple Sclerosis Society; American Cancer Society","keywords":"Antibody; Medicine; Lactosylceramide; Immunology; Nephelometry; Multiple sclerosis; Biomarker; Clinically isolated syndrome; Internal medicine; Gastroenterology; Chemistry","score_opus":0.041348762996198586,"score_gpt":0.3008483055213353,"score_spread":0.2594995425251367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033743882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8357457,0.000117218944,0.00003061609,0.16139841,0.00029590898,0.001167053,0.000012975034,0.00027177672,0.0009603617],"genre_scores_gemma":[0.974771,0.00066895946,0.0001684953,0.023946535,0.00020862091,0.00008095498,0.000027584974,0.000067013105,0.00006084242],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967133,0.0004191295,0.0007480475,0.0009516301,0.000358761,0.00080913573],"domain_scores_gemma":[0.9985239,0.00033632942,0.00015109651,0.0005554009,0.00017022037,0.0002630665],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018411655,0.00037423888,0.00073672656,0.0004730189,0.00014306446,0.000024857824,0.00033361372,0.00021872667,0.00016613843],"category_scores_gemma":[0.0027971994,0.00037557082,0.00012490527,0.00090989156,0.0002678897,0.00020564432,0.00043946458,0.0011716327,0.0006208379],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040529897,0.00020138574,0.17443131,0.00012046003,0.00006321044,0.0010521553,0.0010275863,0.00067443436,0.79426825,0.00018229612,0.0021428547,0.021783069],"study_design_scores_gemma":[0.0027381899,0.002084973,0.96002954,0.00001846466,0.00002444329,0.0001427031,0.000019378316,0.0022947986,0.015583378,0.0000209524,0.01684381,0.00019935006],"about_ca_topic_score_codex":0.000026687094,"about_ca_topic_score_gemma":0.000044505283,"teacher_disagreement_score":0.7855983,"about_ca_system_score_codex":0.000028101393,"about_ca_system_score_gemma":0.00008400598,"threshold_uncertainty_score":0.99986964},"labels":[],"label_agreement":null},{"id":"W3048577711","doi":"10.1212/nxi.0000000000000870","title":"Interleukin-26, preferentially produced by T <sub>H</sub> 17 lymphocytes, regulates CNS barrier function","year":2020,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Vlaamse regering; Centre de recherche du CHU Sainte-Justine; Multiple Sclerosis Society; Fonds de Recherche du Québec - Santé; Fonds Wetenschappelijk Onderzoek; Multiple Sclerosis Society of Canada","keywords":"Function (biology); Chemistry; Cell biology; Biology","score_opus":0.012176076734275058,"score_gpt":0.19114320554901484,"score_spread":0.17896712881473978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048577711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867055,0.0016585581,0.00011901304,0.005589325,0.0031972243,0.0010904007,0.000081049846,0.0012841726,0.0002747503],"genre_scores_gemma":[0.9943713,0.0005813546,0.000008891126,0.0034071223,0.0002305225,0.00017969709,0.00072588865,0.00017756756,0.00031767308],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99437517,0.0015894512,0.0010830652,0.0017483067,0.00013798157,0.0010660548],"domain_scores_gemma":[0.9976845,0.00038824536,0.00065997615,0.00095367903,0.00019545096,0.000118189375],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021724569,0.0008513474,0.0008712201,0.00032391155,0.0005724055,0.0000684705,0.00071200577,0.000993224,0.00035234424],"category_scores_gemma":[0.00043292472,0.00087160314,0.0003284391,0.00048552462,0.00052641914,0.0004961937,0.00034136508,0.0010320581,0.002250105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003908694,0.00017344873,0.0013973737,0.000030599782,0.0003811856,0.000059720358,0.0002715121,0.000077151264,0.9607567,0.00016576343,0.01137529,0.021402571],"study_design_scores_gemma":[0.004690427,0.0031713585,0.0398648,0.000012285356,0.00046950494,0.0002929203,0.000016546324,0.000101777456,0.9134015,0.00012234083,0.03725998,0.00059655093],"about_ca_topic_score_codex":0.0000117473055,"about_ca_topic_score_gemma":0.000014664473,"teacher_disagreement_score":0.047355182,"about_ca_system_score_codex":0.00005259419,"about_ca_system_score_gemma":0.00016709937,"threshold_uncertainty_score":0.9993735},"labels":[],"label_agreement":null},{"id":"W3092849879","doi":"10.1212/nxi.0000000000000899","title":"Childhood choreoathetosis secondary to hyper-IgM syndrome (CD40 ligand deficiency)","year":2020,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Toronto Western Hospital","funders":"Hospital for Sick Children","keywords":"Choreoathetosis; CD40; Immunology; Medicine; Immune system; Biology; Genetics; Dystonia","score_opus":0.009183558152803077,"score_gpt":0.19583855613512058,"score_spread":0.1866549979823175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092849879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9683152,0.0041465233,0.0001688864,0.020532535,0.0022802812,0.0011723894,0.000045921934,0.000867521,0.002470771],"genre_scores_gemma":[0.9839189,0.0002143307,0.000020962425,0.015179765,0.000026178173,0.000113406786,0.00016647113,0.00013396061,0.000225994],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9944497,0.00094000576,0.0012547311,0.0017113761,0.00016381832,0.0014804028],"domain_scores_gemma":[0.9978178,0.00039416188,0.0004572598,0.0011065641,0.00014926585,0.00007496364],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031479757,0.0008373685,0.0010123026,0.00054208963,0.00092143024,0.000076762575,0.0014564827,0.00077920826,0.00060721027],"category_scores_gemma":[0.000628652,0.00088369224,0.00036695827,0.0011140832,0.00068532827,0.0004636354,0.0006283814,0.0022647087,0.0064422856],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007442717,0.0003720543,0.0012479157,0.000039177594,0.000102515616,0.00020000138,0.0020474098,0.0005858102,0.97241,0.00081204716,0.00069900847,0.020739753],"study_design_scores_gemma":[0.006326787,0.008402168,0.6903909,0.000035435365,0.0002647356,0.005608201,0.00027532576,0.0001287215,0.07833779,0.00042899398,0.20803067,0.0017702682],"about_ca_topic_score_codex":0.00003406457,"about_ca_topic_score_gemma":0.0000031818818,"teacher_disagreement_score":0.89407223,"about_ca_system_score_codex":0.000025728821,"about_ca_system_score_gemma":0.00020661106,"threshold_uncertainty_score":0.9993614},"labels":[],"label_agreement":null},{"id":"W3105268192","doi":"10.1212/nxi.0000000000000920","title":"Mendelian randomization study shows no causal effects of serum urate levels on the risk of MS","year":2020,"lang":"en","type":"review","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; National Institute for Health and Care Research; Wellcome Trust","keywords":"Mendelian randomization; Internal medicine; Randomization; Causal inference; Medicine; Genetics; Randomized controlled trial; Gene; Biology; Genetic variants; Genotype","score_opus":0.027475793085858752,"score_gpt":0.2815630983281582,"score_spread":0.25408730524229944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105268192","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48633084,0.47832143,0.00009689324,0.0029549024,0.0054506366,0.025045102,0.000320125,0.000586615,0.0008934739],"genre_scores_gemma":[0.106755406,0.8908453,0.000023323939,0.0008883388,0.00039808382,0.00045808626,0.00009990407,0.00033739998,0.0001941873],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9875872,0.0071317013,0.0025667814,0.0013682673,0.0007015651,0.00064444786],"domain_scores_gemma":[0.9887952,0.005191295,0.003505454,0.0020205665,0.00036067684,0.00012679197],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00069228985,0.0011359166,0.0044094073,0.00075174187,0.00021197583,0.000021153483,0.00085918175,0.0009249658,0.00011281802],"category_scores_gemma":[0.0062169447,0.0008046688,0.0008828974,0.0010679937,0.00051945425,0.00013727504,0.00039092964,0.003263351,0.00025842388],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018609332,0.00605224,0.0065346053,0.047630668,0.016013807,0.007136303,0.0024081965,0.00073820335,0.060027868,0.0009402235,0.003008096,0.8309005],"study_design_scores_gemma":[0.057058774,0.082478315,0.13795678,0.006292631,0.06789911,0.0056146714,0.000096794814,0.0025562285,0.005999565,0.00024173177,0.6304659,0.0033394997],"about_ca_topic_score_codex":0.000019762985,"about_ca_topic_score_gemma":0.0000060093275,"teacher_disagreement_score":0.82756096,"about_ca_system_score_codex":0.000054587916,"about_ca_system_score_gemma":0.00043609994,"threshold_uncertainty_score":0.99944043},"labels":[],"label_agreement":null},{"id":"W3112296245","doi":"10.1212/nxi.0000000000000931","title":"Interleukin-15 enhances proinflammatory T-cell responses in patients with MS and EAE","year":2020,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Natural Sciences and Engineering Research Council of Canada","funders":"Canadian Institutes of Health Research","keywords":"Proinflammatory cytokine; Interleukin; Medicine; Immunology; Inflammation; Cancer research; Cytokine","score_opus":0.006909339785048311,"score_gpt":0.18631728064276215,"score_spread":0.17940794085771383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112296245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99272543,0.0003474977,0.00003127618,0.0036091765,0.0014825753,0.0007707236,0.000004320867,0.0002601315,0.0007688951],"genre_scores_gemma":[0.99658275,0.000105406696,0.000015621656,0.0025904295,0.000039629376,0.00005601944,0.00009675187,0.00006170427,0.00045167163],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99657506,0.0010964235,0.0007512855,0.00091600924,0.00008597737,0.0005752172],"domain_scores_gemma":[0.9985998,0.00037728998,0.00043078154,0.0004106531,0.00013220885,0.00004924706],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017515766,0.00045184532,0.0005244341,0.00039638203,0.00022060602,0.00004109044,0.00031714202,0.000411451,0.00033133468],"category_scores_gemma":[0.0002840835,0.0004220945,0.00007391415,0.00031701272,0.0004970604,0.00054414384,0.00019191611,0.001390529,0.0005935605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012858338,0.00024822543,0.13152792,0.00005345084,0.00005482746,0.000059339494,0.0008760932,0.0000405253,0.8514884,0.00012116315,0.0009375948,0.0017340957],"study_design_scores_gemma":[0.006536126,0.0051109954,0.8874597,0.000019658826,0.000046897196,0.00013179825,0.000053706863,0.00006672464,0.07358454,0.000020334439,0.026554672,0.00041485403],"about_ca_topic_score_codex":0.000026652153,"about_ca_topic_score_gemma":0.000025878211,"teacher_disagreement_score":0.7779039,"about_ca_system_score_codex":0.000023048444,"about_ca_system_score_gemma":0.00007102201,"threshold_uncertainty_score":0.9998231},"labels":[],"label_agreement":null},{"id":"W3121035814","doi":"10.1212/nxi.0000000000000941","title":"CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS","year":2021,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"European Regional Development Fund; Instituto de Salud Carlos III; Ministerio de Ciencia e Innovación; Lundbeckfonden; Generalitat de Catalunya; Red Española de Esclerosis Múltiple; Ministerio de Ciencia, Innovación y Universidades","keywords":"Medicine; Internal medicine","score_opus":0.02142667859796603,"score_gpt":0.265089800017641,"score_spread":0.24366312141967494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121035814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845965,0.00012256172,0.00000610239,0.013083413,0.00030295915,0.0012784111,0.000022402828,0.00021062935,0.00037703273],"genre_scores_gemma":[0.99720764,0.00011165184,0.00008570007,0.0020365326,0.00007439788,0.00013875769,0.00014646801,0.00008049614,0.00011836214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99605376,0.000837676,0.00067001145,0.0010464019,0.000524112,0.00086802227],"domain_scores_gemma":[0.99736303,0.00034386714,0.00038314253,0.000891811,0.0008977409,0.00012039138],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014867108,0.00042426266,0.00076511496,0.00046825147,0.00019855694,0.00003641619,0.0002304804,0.00030250204,0.00018023845],"category_scores_gemma":[0.001778991,0.00038231985,0.00010008469,0.0009192421,0.00047380308,0.00029980764,0.00030505392,0.0013909476,0.00010760326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004186596,0.0008173962,0.8947416,0.00010621849,0.00013463391,0.0030990557,0.00013962202,0.00010022162,0.09113706,0.000059221722,0.00022037166,0.0052579823],"study_design_scores_gemma":[0.0077161365,0.0019607309,0.98028535,0.00007014391,0.000050647177,0.00027904258,0.000018260791,0.00023110522,0.007975527,0.00002971008,0.0011539739,0.00022936627],"about_ca_topic_score_codex":0.000008321987,"about_ca_topic_score_gemma":0.000054448807,"teacher_disagreement_score":0.08554373,"about_ca_system_score_codex":0.000058674028,"about_ca_system_score_gemma":0.00021496962,"threshold_uncertainty_score":0.99986285},"labels":[],"label_agreement":null},{"id":"W3193427671","doi":"10.1212/nxi.0000000000001057","title":"COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America","year":2021,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada; University of British Columbia","funders":"Janssen Pharmaceuticals; Teva Pharmaceutical Industries; National Center for Advancing Translational Sciences; National Cancer Institute; Sanofi Genzyme; Greenwich Biosciences; EMD Serono; Genentech; National Heart, Lung, and Blood Institute; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; BioDelivery Sciences International; MedDay Pharmaceuticals; Horizon Pharmaceuticals; Sanofi; GW Pharmaceuticals; Bristol-Myers Squibb; CSL Behring; AveXis; Pfizer; Biogen; Celgene; U.S. Department of Defense; TG Therapeutics","keywords":"Medicine; Neuromyelitis optica; Internal medicine; Multiple sclerosis; Comorbidity; Rituximab; Pediatrics; Immunology; Lymphoma","score_opus":0.009756802565880364,"score_gpt":0.2588710660790786,"score_spread":0.24911426351319826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193427671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96453285,0.00020526971,0.000036596863,0.033220585,0.0001585094,0.0015644472,0.00004171311,0.0001363517,0.00010365164],"genre_scores_gemma":[0.9932541,0.0029972459,0.00007175683,0.0030216493,0.00004525217,0.00014011734,0.00036225436,0.00007743083,0.00003018519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954815,0.0009864417,0.00075277756,0.0013502148,0.00046983684,0.0009592494],"domain_scores_gemma":[0.9978126,0.00054377347,0.00022965639,0.0008470461,0.00009918925,0.00046768997],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000120327306,0.00049574673,0.0007977453,0.00075994735,0.00020055336,0.000039284263,0.0002275839,0.00016019127,0.00008753479],"category_scores_gemma":[0.0031236012,0.0004813658,0.00008920418,0.0011612636,0.0008157364,0.00027427854,0.00041018976,0.0013126043,0.000032313757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064542163,0.00051856897,0.9793965,0.00016610205,0.000039840394,0.0028669874,0.00024256225,0.0013282009,0.004253746,0.00005819707,0.000014392103,0.004660649],"study_design_scores_gemma":[0.008187733,0.0017488234,0.98535115,0.000026431162,0.00004147098,0.000087972985,0.000015937474,0.0016989108,0.000110020206,0.00006223573,0.0023822507,0.0002870903],"about_ca_topic_score_codex":0.00023671307,"about_ca_topic_score_gemma":0.0021613876,"teacher_disagreement_score":0.030198934,"about_ca_system_score_codex":0.000101493664,"about_ca_system_score_gemma":0.0005524814,"threshold_uncertainty_score":0.9997638},"labels":[],"label_agreement":null},{"id":"W3208942552","doi":"10.1212/nxi.0000000000001098","title":"Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy","year":2021,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"Instituto de Salud Carlos III; Fondazione Regionale per la Ricerca Biomedica; Universitat Autònoma de Barcelona; Grifols; GBS/CIDP Foundation International; Fondazione Cariplo; Sanofi; European Commission; Sarepta Therapeutics; Ministero della Salute; CSL Behring; Teva Pharmaceutical Industries; Medical Research Council; Biogen; Celgene","keywords":"Medicine; Rituximab; Internal medicine; Gastroenterology; Autoantibody; Modified Rankin Scale; Titer; Antibody; Immunology","score_opus":0.0106185965670401,"score_gpt":0.26963807514687216,"score_spread":0.25901947857983204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208942552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811206,0.0018653736,0.0000057650177,0.013957101,0.0014852518,0.0003699386,0.000006954289,0.00021859196,0.00097042584],"genre_scores_gemma":[0.98565,0.0041029337,0.000091183436,0.009699855,0.00012019478,0.000020794852,0.000035972473,0.00006970459,0.0002093564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99613017,0.001169803,0.0009216356,0.0010118001,0.00020165276,0.00056496466],"domain_scores_gemma":[0.99833584,0.00036217817,0.000224719,0.0007695659,0.00018403643,0.00012368686],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003336599,0.00036670035,0.00081915455,0.00028817367,0.00015288938,0.00003715991,0.00016120421,0.0004666121,0.000076500866],"category_scores_gemma":[0.001208715,0.0003847308,0.0001540378,0.00058071385,0.0006492721,0.00026699263,0.00024834357,0.0016666148,0.000045279536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012135281,0.0005120691,0.49152687,0.00008930576,0.000043900716,0.009949028,0.00017041457,0.000057338886,0.482616,0.00087485916,0.0008900759,0.012056599],"study_design_scores_gemma":[0.0036445044,0.0009614495,0.97719634,0.000020962008,0.00005466302,0.002361634,0.000037055936,0.0003386807,0.001346902,0.0001397826,0.01367486,0.00022314937],"about_ca_topic_score_codex":0.000018292074,"about_ca_topic_score_gemma":0.00008161114,"teacher_disagreement_score":0.4856695,"about_ca_system_score_codex":0.000010616506,"about_ca_system_score_gemma":0.00022506059,"threshold_uncertainty_score":0.99986047},"labels":[],"label_agreement":null},{"id":"W3211591349","doi":"10.1212/nxi.0000000000001111","title":"Analysis of Macrophages and Peptidergic Fibers in the Skin of Patients With Painful Diabetic Polyneuropathy","year":2021,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novo Nordisk Fonden; Lundbeckfonden; Steno Diabetes Center Aarhus; Ipsen; Alnylam Pharmaceuticals","keywords":"Pathogenesis; Innate immune system; Immune system; Diabetic neuropathy; Neuropathic pain; Macrophage; Diabetes mellitus","score_opus":0.004309567778639061,"score_gpt":0.204119199245915,"score_spread":0.19980963146727596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211591349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977012,0.00016140011,0.00001770923,0.0015215811,0.0000836169,0.00038616237,0.000015227649,0.000018295103,0.00009476575],"genre_scores_gemma":[0.9988168,0.00014828758,0.000058224286,0.0008260422,0.000008715743,0.000017604909,0.0000842249,0.000022490469,0.000017634407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760085,0.0009047966,0.0005211784,0.00045463283,0.00024955507,0.0002689713],"domain_scores_gemma":[0.9982906,0.0005870771,0.0003424403,0.00058900187,0.00015594774,0.00003491082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020109354,0.00021806668,0.00062494463,0.0005192444,0.00005639301,0.000008002715,0.00012784854,0.0001195927,0.000031545867],"category_scores_gemma":[0.00025846533,0.0001614782,0.00012246984,0.0010729334,0.0002783725,0.00007603277,0.000071398674,0.00034194704,0.000002011734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008066722,0.00056940754,0.94439036,0.00006556588,0.0004304734,0.0008280936,0.00050851493,0.00025730717,0.05021448,0.00022925864,0.000005718244,0.0016941688],"study_design_scores_gemma":[0.0023045626,0.0017689246,0.98953766,0.000010774049,0.0010242704,0.00009136185,0.000035734884,0.0005057655,0.00453563,0.00006200586,0.0000427535,0.00008057907],"about_ca_topic_score_codex":0.000016908236,"about_ca_topic_score_gemma":0.000030661216,"teacher_disagreement_score":0.04567885,"about_ca_system_score_codex":0.0000068620416,"about_ca_system_score_gemma":0.000051415216,"threshold_uncertainty_score":0.658489},"labels":[],"label_agreement":null},{"id":"W3215557511","doi":"10.1212/nxi.0000000000001092","title":"COVID-19 Infection in Fingolimod- or Siponimod-Treated Patients","year":2021,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Novartis Pharma","keywords":"Fingolimod; Coronavirus disease 2019 (COVID-19); Virology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Medicine; Coronavirus Infections; Multiple sclerosis; Internal medicine; Immunology; Infectious disease (medical specialty)","score_opus":0.015387191711300739,"score_gpt":0.2591846777916339,"score_spread":0.24379748608033316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215557511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965135,0.00017678866,0.00018761602,0.001399123,0.00093493325,0.0003717846,0.000011531826,0.00010224175,0.00030248688],"genre_scores_gemma":[0.99247676,0.00088994874,0.000043102664,0.005568055,0.00020935106,0.00006275407,0.0004513099,0.0000626732,0.0002360601],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99667513,0.0009712154,0.0006340095,0.0009830632,0.00017179897,0.0005647977],"domain_scores_gemma":[0.9985452,0.00014371893,0.00026108447,0.00069786573,0.00018368289,0.00016839142],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023176042,0.0003517305,0.0003806828,0.00030625763,0.0002142021,0.00004031529,0.00024362333,0.00048391064,0.00011948508],"category_scores_gemma":[0.002726472,0.00036555837,0.0001312972,0.00053355657,0.00016441419,0.00002983619,0.00026294193,0.00051145384,0.000043736905],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013693814,0.00025153928,0.25233868,0.000035131845,0.000041134554,0.0003181469,0.000075247866,0.0022542076,0.7417763,0.00017692844,0.0003281015,0.0010352035],"study_design_scores_gemma":[0.004484208,0.0009692058,0.874139,0.000006521608,0.00005686864,0.00050349167,0.000006408478,0.0004804169,0.08175866,0.00016158259,0.037021093,0.00041254805],"about_ca_topic_score_codex":0.00013946233,"about_ca_topic_score_gemma":0.00060369534,"teacher_disagreement_score":0.6600176,"about_ca_system_score_codex":0.000029382601,"about_ca_system_score_gemma":0.00046714643,"threshold_uncertainty_score":0.99987966},"labels":[],"label_agreement":null},{"id":"W4200202893","doi":"10.1212/nxi.0000000000001119","title":"Stress Signal ULBP4, an NKG2D Ligand, Is Upregulated in Multiple Sclerosis and Shapes CD8 <sup>+</sup> T-Cell Behaviors","year":2021,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Canadian Institutes of Health Research; Fonds de Recherche du Québec - Santé; University of Washington","keywords":"NKG2D; Downregulation and upregulation; Multiple sclerosis; Immune system; CD8; Signal transduction; Cytotoxic T cell","score_opus":0.018137619926697414,"score_gpt":0.21141883757537383,"score_spread":0.19328121764867642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200202893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939765,0.0010544915,0.00003114899,0.0023533963,0.0015018852,0.00049386144,0.000026832022,0.00028431072,0.0002775863],"genre_scores_gemma":[0.9950668,0.0008295052,0.000022333783,0.0020970928,0.000051822717,0.00006418529,0.0004703494,0.00008915902,0.0013087515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949417,0.0016919711,0.0010419341,0.0013692414,0.00010470396,0.00085045316],"domain_scores_gemma":[0.99808794,0.0005033106,0.00040074674,0.0007012963,0.00024100103,0.00006571818],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024012662,0.0005897188,0.0006843922,0.00057396496,0.0004950673,0.00008837526,0.00037973898,0.0012380234,0.001125837],"category_scores_gemma":[0.00018683095,0.00066861743,0.0001731324,0.00048500294,0.00052449404,0.00075337075,0.00029097294,0.0021346186,0.00039665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011263413,0.00057542784,0.025377264,0.000026704261,0.000051871488,0.0001742139,0.0009976961,0.0007735039,0.9667298,0.000050080816,0.00052430574,0.0035927726],"study_design_scores_gemma":[0.0056491643,0.0017383953,0.31980023,0.000042751435,0.00013644228,0.0013548057,0.00031859678,0.0051091067,0.65807956,0.00005924691,0.007087593,0.0006240967],"about_ca_topic_score_codex":0.00015165033,"about_ca_topic_score_gemma":0.00008691987,"teacher_disagreement_score":0.30865026,"about_ca_system_score_codex":0.00003754002,"about_ca_system_score_gemma":0.00010755994,"threshold_uncertainty_score":0.9997873},"labels":[],"label_agreement":null},{"id":"W4200326784","doi":"10.1212/nxi.0000000000001126","title":"Leveraging Visual Outcome Measures to Advance Therapy Development in Neuroimmunologic Disorders","year":2021,"lang":"en","type":"review","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Outcome (game theory); Psychology; Psychotherapist; Economics","score_opus":0.11840327690146815,"score_gpt":0.3913749760219827,"score_spread":0.27297169912051455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200326784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12013179,0.87009555,0.000040962896,0.0029247836,0.0014193648,0.004724973,0.00000803636,0.00042282522,0.0002317267],"genre_scores_gemma":[0.0042007375,0.99207413,0.00017945231,0.0014920804,0.00014693347,0.0012334236,0.00021302802,0.00029251544,0.000167724],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9892306,0.0028082212,0.002818476,0.0025370938,0.000838848,0.0017668084],"domain_scores_gemma":[0.99567115,0.0014209002,0.00080623303,0.0015662092,0.00029841304,0.00023708733],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00070953567,0.0015210066,0.004611868,0.0023344147,0.00041345134,0.00008413313,0.00092830276,0.00093649223,0.00008538513],"category_scores_gemma":[0.0034452055,0.0014078763,0.00076136284,0.0019369387,0.00042966453,0.00023086749,0.0010966272,0.004107222,0.00037913644],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046467708,0.00045208097,0.0027593374,0.0013144091,0.0002521101,0.00090887246,0.00024315536,0.00004751772,0.001480715,0.000018120581,0.000063655745,0.99199533],"study_design_scores_gemma":[0.0018927617,0.0012144956,0.12486126,0.0011418328,0.00013398145,0.0006282767,0.000015341117,0.000025615798,0.00006849944,0.000006356039,0.86927474,0.0007368122],"about_ca_topic_score_codex":0.000024611798,"about_ca_topic_score_gemma":0.000082787985,"teacher_disagreement_score":0.99125856,"about_ca_system_score_codex":0.0002711325,"about_ca_system_score_gemma":0.00085929193,"threshold_uncertainty_score":0.9997539},"labels":[],"label_agreement":null},{"id":"W4205282783","doi":"10.1212/nxi.0000000000001134","title":"Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG–Associated Experimental Autoimmune Encephalomyelitis","year":2022,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Medicine; Neuromyelitis optica; Immunology; Experimental autoimmune encephalomyelitis; Optic neuritis; Antibody; Encephalomyelitis; Pathology; Immunoglobulin G; Luxol fast blue stain; Myelin; Central nervous system; Internal medicine","score_opus":0.025467683437563008,"score_gpt":0.30494597273452806,"score_spread":0.27947828929696505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205282783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825692,0.0008738658,0.0000042520173,0.0120753385,0.0013632687,0.0017346079,0.00019894552,0.00067691325,0.0005035783],"genre_scores_gemma":[0.99428535,0.0012200224,0.00005069704,0.0009886007,0.00017956524,0.00064977194,0.0017468514,0.00012992848,0.0007492355],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9941013,0.0016409751,0.0010034615,0.001300333,0.0007659423,0.0011880179],"domain_scores_gemma":[0.9975727,0.00052530825,0.00051986106,0.0009932745,0.00022546484,0.00016335232],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031799416,0.00065920566,0.0010379005,0.000714587,0.0013320056,0.000049262704,0.0004902883,0.00023269624,0.00155479],"category_scores_gemma":[0.0007512549,0.00061029283,0.0003501027,0.0008745409,0.0007139439,0.00029179468,0.0008315649,0.0013915884,0.0003083944],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030285416,0.0011354036,0.012580427,0.000016573173,0.000252076,0.0008595924,0.0006965241,0.00019750804,0.97080487,0.00007838993,0.0006992502,0.009650844],"study_design_scores_gemma":[0.0075005037,0.015776673,0.8904667,0.000012368818,0.00010868493,0.0011648164,0.0002567484,0.0021513172,0.029896375,0.000018142919,0.05217817,0.00046952945],"about_ca_topic_score_codex":0.00016615925,"about_ca_topic_score_gemma":0.000011103306,"teacher_disagreement_score":0.9409085,"about_ca_system_score_codex":0.00030653345,"about_ca_system_score_gemma":0.00024451155,"threshold_uncertainty_score":0.9999681},"labels":[],"label_agreement":null},{"id":"W4220654663","doi":"10.1212/nxi.0000000000001153","title":"Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children","year":2022,"lang":"en","type":"review","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"UCB Pharma; National Cancer Institute; National Health and Medical Research Council; Medical Research Council; Canadian Institutes of Health Research; Epilepsy Society; Ontario Institute for Regenerative Medicine; Action Medical Research; Sparks; Ono Pharmaceutical; National Multiple Sclerosis Society; Genentech; University of Oxford; National Institutes of Health; Epilepsy Research UK; Great Ormond Street Hospital Charity; CSL Behring; National Institute for Health and Care Research; Multiple Sclerosis Society; Petre Foundation; Wellcome Trust; Cerebral Palsy Alliance; Pfizer; Biogen; Hospital for Sick Children; Sanofi; Sarepta Therapeutics","keywords":"Irritability; Medicine; Context (archaeology); Pediatrics; Ataxia; Regimen; Intensive care medicine; Psychiatry; Cognition; Surgery","score_opus":0.0322765953042198,"score_gpt":0.2892690124645949,"score_spread":0.25699241716037513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220654663","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24933295,0.7461551,6.708729e-7,0.00039617228,0.00030049554,0.0033991835,0.000050080645,0.00012810496,0.00023724751],"genre_scores_gemma":[0.009139547,0.9884548,0.000027869153,0.0003285022,0.000014165019,0.0012422554,0.0005379231,0.0001520705,0.00010283046],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9946226,0.0010931343,0.001712225,0.0014945818,0.00036511593,0.00071236124],"domain_scores_gemma":[0.99714106,0.00054606015,0.0010444112,0.0011439837,0.000027436427,0.00009705296],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022526341,0.0009025916,0.0030636191,0.001016584,0.00017519433,0.000017684935,0.0005065794,0.0006716711,0.00024657993],"category_scores_gemma":[0.000113424605,0.0008407959,0.0005385404,0.00090074836,0.00046156853,0.00012581886,0.00090434076,0.0019213398,0.00004631671],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045110213,0.001569049,0.02713384,0.0075748907,0.0011341632,0.0119539,0.000028070883,0.000013595157,0.000011651398,0.00044161905,0.000057052646,0.9496311],"study_design_scores_gemma":[0.0029464038,0.003949011,0.63155407,0.0007151182,0.0023863276,0.01748404,0.0000028480695,0.00001307238,0.0000021020578,0.00012649562,0.34032375,0.00049679657],"about_ca_topic_score_codex":0.000032330536,"about_ca_topic_score_gemma":0.0000018260647,"teacher_disagreement_score":0.9491343,"about_ca_system_score_codex":0.000051216204,"about_ca_system_score_gemma":0.00009049356,"threshold_uncertainty_score":0.9994043},"labels":[],"label_agreement":null},{"id":"W4220836929","doi":"10.1212/nxi.0000000000001156","title":"Cryptococcal Meningitis Reported With Fingolimod Treatment","year":2022,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Fungal Infections and Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute of Allergy and Infectious Diseases; U.S. Department of Veterans Affairs","keywords":"Fingolimod; Medicine; Headaches; Pediatrics; Adverse effect; Incidence (geometry); Internal medicine; Multiple sclerosis; Surgery; Psychiatry","score_opus":0.021549688483744136,"score_gpt":0.24719200173713005,"score_spread":0.2256423132533859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220836929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984353,0.0001136196,0.000040160732,0.010266811,0.0005757178,0.00093786384,0.000010129084,0.00041417681,0.003288501],"genre_scores_gemma":[0.99716204,0.00010085597,0.000076432094,0.0011062081,0.00009690714,0.0005925766,0.00007553923,0.00006136471,0.000728092],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977135,0.00038291985,0.000501314,0.000690577,0.00024291797,0.00046875182],"domain_scores_gemma":[0.99868137,0.00020385701,0.00028535945,0.0006492351,0.000107994456,0.000072195035],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011915704,0.00032201144,0.00050602836,0.0003699904,0.0009031055,0.000018394023,0.00011194885,0.000097500924,0.00032433684],"category_scores_gemma":[0.000106716165,0.00028399497,0.00014357416,0.00045735567,0.00024945973,0.000100018195,0.00016550864,0.0007553155,0.000039656356],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0122334985,0.002236854,0.20664765,0.0000593456,0.0012286142,0.016067857,0.0012778124,0.006170002,0.73389226,0.0035972747,0.002312312,0.014276482],"study_design_scores_gemma":[0.0060221953,0.03384237,0.8161612,0.000006540722,0.00044394794,0.033430614,0.000066976965,0.0016636733,0.0044352757,0.00015519958,0.103392564,0.00037945],"about_ca_topic_score_codex":0.000062201376,"about_ca_topic_score_gemma":0.000019668556,"teacher_disagreement_score":0.729457,"about_ca_system_score_codex":0.00009291549,"about_ca_system_score_gemma":0.0001372604,"threshold_uncertainty_score":0.9999612},"labels":[],"label_agreement":null},{"id":"W4224311696","doi":"10.1212/nxi.0000000000001173","title":"Programmed Cell Death Protein 1–Positive CD8 <sup>+</sup> T Cells in Multiple Sclerosis","year":2022,"lang":"en","type":"letter","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Multiple sclerosis; Programmed cell death; CD8; Cytotoxic T cell; Cell; Cell biology; Chemistry; Biology; Immunology; Apoptosis; Biochemistry; Immune system; In vitro","score_opus":0.036903279635318836,"score_gpt":0.24930107587053896,"score_spread":0.21239779623522012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224311696","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72936285,0.00017332291,0.0000073689484,0.26020277,0.00068009255,0.007402305,0.00011370339,0.00049336115,0.001564228],"genre_scores_gemma":[0.34332845,0.0015229707,0.00043200096,0.60504293,0.0039110896,0.008244956,0.006180553,0.002073212,0.029263835],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.98689544,0.004549437,0.0018269886,0.0028868676,0.001360801,0.0024804585],"domain_scores_gemma":[0.9945129,0.0016336875,0.00091046724,0.0024162652,0.00032483207,0.00020182891],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0007610878,0.0014410419,0.0020095517,0.0023871625,0.0005064979,0.00012338502,0.0012625119,0.0024991482,0.002992654],"category_scores_gemma":[0.0005398596,0.001625795,0.0006945285,0.0013522925,0.00080955174,0.00028819396,0.0009522858,0.016346335,0.00046823052],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072471076,0.00088062225,0.0028252082,0.00055462896,0.00020909065,0.020625127,0.0005650025,0.0008282551,0.9185552,0.000014401677,0.041643925,0.0060514077],"study_design_scores_gemma":[0.014213957,0.0152398925,0.02689005,0.00017170189,0.00043574377,0.0026081153,0.00004403769,0.0071073635,0.07376167,0.0001350982,0.8576356,0.001756763],"about_ca_topic_score_codex":0.00033292908,"about_ca_topic_score_gemma":0.000026763304,"teacher_disagreement_score":0.84479356,"about_ca_system_score_codex":0.00040991395,"about_ca_system_score_gemma":0.0006521968,"threshold_uncertainty_score":0.99983394},"labels":[],"label_agreement":null},{"id":"W4233752323","doi":"10.1212/nxi.0000000000000276","title":"Restoring immune tolerance in neuromyelitis optica","year":2016,"lang":"en","type":"review","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Guthy-Jackson Charitable Foundation","keywords":"Neuromyelitis optica; Medicine; Immune system; Immune tolerance; Immunology; Disease; Neuroscience; Bioinformatics; Multiple sclerosis; Psychology; Internal medicine; Biology","score_opus":0.060791888819849545,"score_gpt":0.3480146735541715,"score_spread":0.28722278473432195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233752323","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014262649,0.9739704,0.0000067216624,0.0037506868,0.0020878795,0.0034936653,0.00004673336,0.0004589273,0.0019223095],"genre_scores_gemma":[0.0010523851,0.9964741,0.000043782748,0.0002706614,0.0005763353,0.00072550826,0.00009928124,0.00030003578,0.00045791283],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908762,0.0021240595,0.0025524967,0.0020853467,0.0006794621,0.0016824256],"domain_scores_gemma":[0.9939773,0.0022443063,0.0009854579,0.0023539846,0.00022423163,0.00021469247],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00056369125,0.0012883468,0.004410936,0.0018959108,0.0002631149,0.000050769533,0.000906292,0.001145138,0.00015554413],"category_scores_gemma":[0.003428774,0.0010487214,0.0009086432,0.0010814174,0.0008227755,0.0003217135,0.00085101253,0.0037817953,0.0009361897],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053864444,0.00015974832,0.00015144961,0.0044615725,0.00014912992,0.002972436,0.00004983339,0.000007335541,0.0032848762,0.00019511975,0.00013215422,0.9878977],"study_design_scores_gemma":[0.0023389596,0.0012460697,0.046682037,0.0054281373,0.0002664817,0.0028908257,0.000001861828,0.00005320118,0.000044107426,0.000035328296,0.9403883,0.0006246548],"about_ca_topic_score_codex":0.000027223741,"about_ca_topic_score_gemma":0.00001502831,"teacher_disagreement_score":0.98727304,"about_ca_system_score_codex":0.00020859556,"about_ca_system_score_gemma":0.00050832616,"threshold_uncertainty_score":0.9999868},"labels":[],"label_agreement":null},{"id":"W4282921382","doi":"10.1212/nxi.0000000000200005","title":"Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival","year":2022,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Saskatchewan Health Quality Council; University of Saskatchewan; Nova Scotia Health Authority; Dalhousie University","funders":"Canadian Institutes of Health Research; Crohn's and Colitis Canada; Department of Health, Western Cape Government; Dalhousie University; Research Nova Scotia; European Committee for Treatment and Research in Multiple Sclerosis; Research Manitoba; Multiple Sclerosis Society; Multiple Sclerosis Trust; Nova Scotia Department of Health and Wellness; Ministry of Health, Saskatchewan; Multiple Sclerosis Society of Canada; Multiple Sclerosis Scientific Research Foundation; National Multiple Sclerosis Society; Michael Smith Health Research BC; Biogen; U.S. Department of Defense","keywords":"Disease; Multiple sclerosis; Association (psychology); Medicine; Oncology; Internal medicine; Psychology; Psychiatry; Psychotherapist","score_opus":0.04376940209504658,"score_gpt":0.26529876956453924,"score_spread":0.22152936746949264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282921382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97378594,0.00016112057,0.00007250939,0.023186551,0.0005032612,0.0018225354,0.000087966764,0.00024517305,0.00013492032],"genre_scores_gemma":[0.9967026,0.00036016462,0.00012321261,0.0013268176,0.00012146953,0.00094610994,0.00014178276,0.00008008945,0.00019774212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967078,0.00071654486,0.00044100994,0.00083267264,0.0006082908,0.00069371244],"domain_scores_gemma":[0.9969648,0.0018290177,0.00034426127,0.0004809076,0.00023059435,0.0001503959],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005495839,0.00030705798,0.00051760685,0.00035645766,0.0011036221,0.000036549834,0.0001905255,0.00010831827,0.00004243253],"category_scores_gemma":[0.0017644027,0.00030581246,0.00012058472,0.0003333282,0.00023091234,0.00018260189,0.00040215376,0.00094162015,0.000008532532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023616243,0.00047213715,0.59124976,0.00023906067,0.0003830217,0.00015397974,0.000762802,0.0012570324,0.36165637,0.00042576113,0.0010798624,0.018703943],"study_design_scores_gemma":[0.0068285903,0.0023761909,0.9733396,0.000010431964,0.00016570208,0.00008125402,0.000082310886,0.006876553,0.0010148953,0.00006224203,0.008943597,0.00021859536],"about_ca_topic_score_codex":0.000024506126,"about_ca_topic_score_gemma":0.00001609708,"teacher_disagreement_score":0.38208985,"about_ca_system_score_codex":0.00012325565,"about_ca_system_score_gemma":0.00012400436,"threshold_uncertainty_score":0.9999394},"labels":[],"label_agreement":null},{"id":"W4295037651","doi":"10.1212/nxi.0000000000200022","title":"CLMP Promotes Leukocyte Migration Across Brain Barriers in Multiple Sclerosis","year":2022,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Immune system; Peripheral blood mononuclear cell; Flow cytometry; Human brain; Multiple sclerosis; Pathology; Microglia; Biology; Inflammation; Antibody; Immunology; Cell; In vitro; Medicine","score_opus":0.046231315994908165,"score_gpt":0.2436534667323145,"score_spread":0.19742215073740632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295037651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853317,0.000040130493,0.00007553734,0.010127085,0.0023380525,0.0013283908,0.0000752688,0.00056786917,0.00011594598],"genre_scores_gemma":[0.9891501,0.00012235818,0.000015608406,0.009785472,0.00008683119,0.0005143649,0.000029137876,0.00016145266,0.00013466901],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9901276,0.004383367,0.0012122791,0.0020921803,0.00074140093,0.0014431645],"domain_scores_gemma":[0.9955742,0.0024668637,0.0006479508,0.0010503028,0.00006080943,0.00019991463],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00072268356,0.0006669989,0.0006724874,0.00071678526,0.001814462,0.00012585775,0.0012089851,0.0002485822,0.00026967147],"category_scores_gemma":[0.0041592163,0.00079548394,0.00024288318,0.0015105365,0.00049278006,0.00061768276,0.0010838611,0.002051621,0.00015610445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011182848,0.00020833094,0.0048866854,0.000015021418,0.0000056605486,0.0008658235,0.00054635224,0.0052036396,0.9846871,0.001350119,0.00016541543,0.0009476068],"study_design_scores_gemma":[0.0032510755,0.0026392147,0.06569291,0.0000072290104,0.000019910673,0.0016744643,0.00007607507,0.017535098,0.89751333,0.00034982312,0.010593872,0.00064698124],"about_ca_topic_score_codex":0.00005053516,"about_ca_topic_score_gemma":0.0001725545,"teacher_disagreement_score":0.087173715,"about_ca_system_score_codex":0.00009713165,"about_ca_system_score_gemma":0.00015953222,"threshold_uncertainty_score":0.999485},"labels":[],"label_agreement":null},{"id":"W4304807432","doi":"10.1212/nxi.0000000000200032","title":"Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3","year":2022,"lang":"en","type":"review","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Institute of Health Services and Policy Research; St. Michael's Hospital; Mount Sinai Hospital","funders":"","keywords":"Term (time); Multiple sclerosis; Association (psychology); Medicine; Internal medicine; Psychology; Psychiatry; Psychotherapist; Physics","score_opus":0.0640300232606055,"score_gpt":0.3304874727833093,"score_spread":0.2664574495227038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304807432","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7842438,0.20968615,0.000009426678,0.00088904845,0.00024668657,0.0046321405,0.000024760757,0.00014800197,0.00011993355],"genre_scores_gemma":[0.045081392,0.9531213,0.000096281234,0.0001105876,0.0000691937,0.00062321295,0.0005170662,0.00021559428,0.0001653548],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9926472,0.002712786,0.0015545073,0.0014386106,0.00087719085,0.0007697539],"domain_scores_gemma":[0.9945002,0.0022806756,0.0017224123,0.0011408727,0.00021456079,0.00014128449],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00066874037,0.00075306563,0.0027862238,0.0007000595,0.0002135022,0.00003678393,0.00040860663,0.0007147178,0.00018289239],"category_scores_gemma":[0.0009842677,0.00060112524,0.00023367222,0.0010571199,0.00079344044,0.00018328823,0.00051147526,0.0031802638,0.000028686914],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00704406,0.0012273797,0.46220878,0.0091087185,0.00025802356,0.0006431411,0.00008938138,0.000024258521,0.002193493,0.000007722671,0.00004807702,0.51714694],"study_design_scores_gemma":[0.006315477,0.01848452,0.86318064,0.0026050135,0.0013530143,0.0013602691,0.000009403954,0.00036670413,0.0001438709,0.000002863076,0.10549585,0.00068239856],"about_ca_topic_score_codex":0.000037941627,"about_ca_topic_score_gemma":0.0001895035,"teacher_disagreement_score":0.74343514,"about_ca_system_score_codex":0.00027013634,"about_ca_system_score_gemma":0.000376518,"threshold_uncertainty_score":0.99964404},"labels":[],"label_agreement":null},{"id":"W4309866766","doi":"10.1212/nxi.0000000000200062","title":"Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis","year":2022,"lang":"en","type":"review","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Mental Health; Canadian Institutes of Health Research; Biogen; Amgen","keywords":"Vitamin D and neurology; Expanded Disability Status Scale; Genome-wide association study; Mendelian randomization; Confounding; Multiple sclerosis; Medicine; Internal medicine; Observational study; Oncology; Genetics; Single-nucleotide polymorphism; Biology; Immunology; Genotype","score_opus":0.05437899373133189,"score_gpt":0.2984337808973357,"score_spread":0.2440547871660038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309866766","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5490708,0.4448271,0.00000307288,0.001609628,0.00038540276,0.0036348298,0.000274727,0.0001504083,0.00004402138],"genre_scores_gemma":[0.030360585,0.96820354,0.00003127071,0.00014290161,0.00006070415,0.00069371675,0.00025364262,0.00014828437,0.00010536591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99285924,0.0027277197,0.0016456966,0.0012509043,0.0007094769,0.0008069772],"domain_scores_gemma":[0.9927162,0.004086189,0.0018451316,0.0010091679,0.00012975553,0.00021355708],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006999001,0.0007391448,0.0029003893,0.0014593775,0.00027878565,0.00002529294,0.00038561813,0.00043879994,0.00010620035],"category_scores_gemma":[0.008612702,0.0006528282,0.00041031936,0.0010961978,0.00038535023,0.0001808186,0.0006620389,0.0027329195,0.000019859117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019351031,0.00036003775,0.68746036,0.0055279355,0.00046301927,0.00022464851,0.00014344645,0.000032810767,0.00030309788,0.00001145742,0.000103016435,0.3034351],"study_design_scores_gemma":[0.0030765063,0.0014067172,0.9287538,0.0005603743,0.0014785379,0.00012754835,0.000009638814,0.00024449002,0.000004574973,0.0000061019086,0.06398848,0.00034324764],"about_ca_topic_score_codex":0.00018943689,"about_ca_topic_score_gemma":0.00044547775,"teacher_disagreement_score":0.5233764,"about_ca_system_score_codex":0.00022346925,"about_ca_system_score_gemma":0.0004456062,"threshold_uncertainty_score":0.99973816},"labels":[],"label_agreement":null},{"id":"W4310593807","doi":"10.1212/nxi.0000000000200046","title":"Single-Cell Transcriptomics Identifies Brain Endothelium Inflammatory Networks in Experimental Autoimmune Encephalomyelitis","year":2022,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Neuroinflammation; Experimental autoimmune encephalomyelitis; Immune system; Biology; Multiple sclerosis; Immunology; Microglia; Transcriptome; Cell biology; Pathology; Inflammation; Gene expression; Medicine; Gene","score_opus":0.009087682087432337,"score_gpt":0.2029845000075888,"score_spread":0.19389681792015648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310593807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922078,0.0016587952,0.00030002827,0.0015447863,0.002835485,0.00073451526,0.000023044196,0.0001475968,0.00054792134],"genre_scores_gemma":[0.9958511,0.00020306365,0.00003308598,0.0025804641,0.00021921386,0.0002535431,0.00029943354,0.0001379071,0.00042221483],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99523157,0.0013864761,0.0010162705,0.0011713443,0.00030427493,0.0008900373],"domain_scores_gemma":[0.99846554,0.00015090944,0.00036502982,0.0008693228,0.000062957224,0.000086254695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042929768,0.0005421466,0.00049180276,0.00041594647,0.0005101951,0.00006416571,0.0008675111,0.00037507343,0.00013669838],"category_scores_gemma":[0.00010140786,0.0007004389,0.00025985992,0.00035476568,0.0004248589,0.000047385533,0.00042663806,0.0012469621,0.000018009781],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012153512,0.0004632764,0.0047497796,0.000016453141,0.000025590974,0.0002313627,0.00033443677,0.011634182,0.98003644,0.00013439688,0.00032984425,0.0008288798],"study_design_scores_gemma":[0.01072137,0.008335207,0.18568997,0.000015445512,0.00007359406,0.0018428395,0.0003966336,0.0097171655,0.69987315,0.00022905575,0.08128955,0.0018160244],"about_ca_topic_score_codex":0.00005347417,"about_ca_topic_score_gemma":0.000074419375,"teacher_disagreement_score":0.2801633,"about_ca_system_score_codex":0.00006294509,"about_ca_system_score_gemma":0.00012314593,"threshold_uncertainty_score":0.9995447},"labels":[],"label_agreement":null},{"id":"W4311910797","doi":"10.1212/nxi.0000000000200071","title":"Long-term Efficacy of Satralizumab in AQP4-IgG–Seropositive Neuromyelitis Optica Spectrum Disorder From SAkuraSky and SAkuraStar","year":2022,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"Neuromyelitis optica; Medicine; Expanded Disability Status Scale; Internal medicine; Gastroenterology; Spectrum disorder; Double blind; Placebo; Antibody; Multiple sclerosis; Immunology; Pathology","score_opus":0.015149344954275105,"score_gpt":0.2691153934503412,"score_spread":0.2539660484960661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311910797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98291034,0.0005605229,0.000018652894,0.014014836,0.000488931,0.0015396131,0.00010551638,0.00014400305,0.00021760569],"genre_scores_gemma":[0.9973385,0.001407559,0.000047460995,0.00063556747,0.00009118586,0.00014277687,0.00020219725,0.00009173331,0.000043027692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99477947,0.001524036,0.001052599,0.0012050273,0.00057823875,0.0008606285],"domain_scores_gemma":[0.99696106,0.001510888,0.00041332748,0.0008759392,0.00009951035,0.00013924818],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002452812,0.0005026959,0.0010244837,0.0007994227,0.00038508367,0.000024614124,0.00041093203,0.00018365617,0.00038706194],"category_scores_gemma":[0.0008337301,0.00053460663,0.00018807103,0.000662343,0.00091387547,0.0002149805,0.001011333,0.0018041611,0.000021635879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008512386,0.0008157913,0.56876576,0.00010026814,0.00020374093,0.0020320693,0.0010271325,0.0005485194,0.39930338,0.00028511544,0.000055566125,0.018350296],"study_design_scores_gemma":[0.007097698,0.0038838247,0.98394454,0.000025457637,0.00010384573,0.00068709045,0.000051318693,0.0007041999,0.0028139965,0.00012727176,0.00029749144,0.0002632541],"about_ca_topic_score_codex":0.0005374021,"about_ca_topic_score_gemma":0.00028577526,"teacher_disagreement_score":0.4151788,"about_ca_system_score_codex":0.00007948481,"about_ca_system_score_gemma":0.0001328996,"threshold_uncertainty_score":0.99971056},"labels":[],"label_agreement":null},{"id":"W4321434823","doi":"10.1212/nxi.0000000000200095","title":"Levels of Soluble Interleukin 6 Receptor and Asp358Ala Are Associated With Cognitive Performance and Alzheimer Disease Biomarkers","year":2023,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute on Aging; Wake Forest University","keywords":"Neuroinflammation; Interleukin 6; Dementia; Disease; Cognition; Medicine; Alzheimer's disease; Receptor; Cytokine; Montreal Cognitive Assessment; Internal medicine; Immunology; Psychology; Neuroscience","score_opus":0.040308740970839974,"score_gpt":0.24822169708073427,"score_spread":0.2079129561098943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321434823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943605,0.00004706486,0.000037675465,0.0033262921,0.00062318495,0.0008453346,0.00007518313,0.00054397964,0.00014078942],"genre_scores_gemma":[0.9975684,0.0005852475,0.00001474228,0.0014013554,0.000033959055,0.00007686011,0.000036177647,0.00009130398,0.00019192873],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9959857,0.0011349022,0.00070881355,0.0011768352,0.0003946988,0.00059907656],"domain_scores_gemma":[0.99705565,0.0013957336,0.0007564744,0.00043577547,0.0001673714,0.00018898759],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003377283,0.00046911606,0.0005021194,0.00071377604,0.00044231027,0.00007449886,0.00028024465,0.00020167556,0.000056056113],"category_scores_gemma":[0.0017713079,0.00045939864,0.0000687445,0.00093221816,0.00092451955,0.000626816,0.00029009808,0.0005730869,0.000078048],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001378319,0.00008087653,0.009845849,0.000053424614,0.000045424895,0.00023843886,0.000203199,0.00014730239,0.98373413,0.0009654106,0.00017899682,0.0031286147],"study_design_scores_gemma":[0.0025406333,0.001489564,0.5971001,0.00008745926,0.00014214004,0.00024386247,0.000032669424,0.010258,0.3871676,0.00019896314,0.0002932042,0.00044582784],"about_ca_topic_score_codex":0.0000017614329,"about_ca_topic_score_gemma":0.0000073966607,"teacher_disagreement_score":0.59656656,"about_ca_system_score_codex":0.000009122789,"about_ca_system_score_gemma":0.00007779307,"threshold_uncertainty_score":0.9997858},"labels":[],"label_agreement":null},{"id":"W4362593230","doi":"10.1212/nxi.0000000000200115","title":"Prolonged Corticosteroids Without Maintenance Immunotherapy for Treatment of Anti-LGI1 Encephalitis","year":2023,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"London Health Sciences Foundation; Academic Medical Organization of Southwestern Ontario; London Health Sciences Centre","keywords":"Medicine; Rituximab; Interquartile range; Autoimmune encephalitis; Regimen; Maintenance therapy; Immunotherapy; Encephalitis; Retrospective cohort study; Surgery; Pediatrics; Internal medicine; Immunology; Chemotherapy; Lymphoma; Cancer","score_opus":0.02988328175396148,"score_gpt":0.295490237983504,"score_spread":0.2656069562295425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885149,0.0002765238,0.00015032451,0.0068777273,0.00071454037,0.0026873157,0.00004009944,0.000519414,0.00021917124],"genre_scores_gemma":[0.9952013,0.0021557717,0.0000876683,0.0009782836,0.000056511657,0.0005443693,0.00020738953,0.00010031517,0.00066840363],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968056,0.00032586188,0.0009448575,0.00088413956,0.00023390012,0.00080565497],"domain_scores_gemma":[0.9978404,0.00047838513,0.00052766106,0.00086522,0.00020558969,0.000082731494],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014042393,0.0004899059,0.0011255635,0.0004226144,0.0002247564,0.000017232756,0.00023137417,0.00035222623,0.00004865439],"category_scores_gemma":[0.00028656962,0.0004118118,0.00039158572,0.00053592894,0.0005164139,0.00014226207,0.000067575944,0.00022358763,0.00010172472],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069398107,0.0011266991,0.17206216,0.00009152444,0.00032792948,0.00057604257,0.00030590539,0.0001662894,0.78453004,0.0005165086,0.00017512811,0.033181924],"study_design_scores_gemma":[0.010158563,0.017955938,0.94949144,0.000016067392,0.00018521394,0.0006201282,0.000013264755,0.0019499279,0.011927625,0.0006082729,0.006841629,0.00023194369],"about_ca_topic_score_codex":0.000020421936,"about_ca_topic_score_gemma":0.0000042813567,"teacher_disagreement_score":0.7774293,"about_ca_system_score_codex":0.000030574032,"about_ca_system_score_gemma":0.000097180215,"threshold_uncertainty_score":0.99983335},"labels":[],"label_agreement":null},{"id":"W4366815631","doi":"10.1212/nxi.0000000000200118","title":"Effect of Ocrelizumab on B- and T-Cell Receptor Repertoire Diversity in Patients With Relapsing Multiple Sclerosis From the Randomized Phase III OPERA Trial","year":2023,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Neurological Disorders and Stroke; Deutscher Akademischer Austauschdienst","keywords":"Ocrelizumab; CD8; Repertoire; Biology; Immunology; T-cell receptor; T cell; Antibody; Antigen; Immune system; Rituximab","score_opus":0.0271945788087527,"score_gpt":0.26228726423221144,"score_spread":0.23509268542345874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366815631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99180937,0.00006343838,0.000001937195,0.002990742,0.00046684156,0.004425896,0.0000360884,0.0001350087,0.000070665716],"genre_scores_gemma":[0.99836373,0.0008869632,0.000009285254,0.00031033537,0.000058819867,0.00015074754,0.00015120175,0.00004477674,0.000024112824],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99470085,0.002859248,0.0007072279,0.0007651668,0.00049103366,0.00047646154],"domain_scores_gemma":[0.9914162,0.007314724,0.00037895108,0.0006845109,0.00013576023,0.00006986451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009405315,0.0003629646,0.0011776797,0.00038801585,0.00048353386,0.000018828116,0.00026484567,0.00022063131,0.000027811853],"category_scores_gemma":[0.0045532933,0.0002370794,0.00016224124,0.0005413395,0.0009099878,0.00014754552,0.00058547856,0.00097325275,0.000026815247],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8888437,0.00035470922,0.04748298,0.000035306748,0.000108907145,0.00003911089,0.0006268176,0.00006694891,0.054360516,0.0000038358853,0.00019678692,0.007880376],"study_design_scores_gemma":[0.6013276,0.010308321,0.38185063,0.000070454655,0.00011707914,0.0000024296623,0.00001304122,0.0013601125,0.004788516,0.0000040464943,0.00004685143,0.000110916706],"about_ca_topic_score_codex":0.00021949409,"about_ca_topic_score_gemma":0.000024094157,"teacher_disagreement_score":0.33436763,"about_ca_system_score_codex":0.0000322231,"about_ca_system_score_gemma":0.000040940995,"threshold_uncertainty_score":0.96678174},"labels":[],"label_agreement":null},{"id":"W4381432934","doi":"10.1212/nxi.0000000000200121","title":"Complement Factor I Gene Variant as a Treatable Cause of Recurrent Aseptic Neutrophilic Meningitis","year":2023,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Aseptic meningitis; Canakinumab; Medicine; Meningitis; Complement factor I; Immunology; Complement system; Inflammation; Complement (music); Monoclonal antibody; Antibody; Gene; Internal medicine; Pediatrics; Genetics; Biology; Anakinra; Disease","score_opus":0.03321239040554943,"score_gpt":0.27375718683264577,"score_spread":0.24054479642709634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381432934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913654,0.00050349865,0.00002478566,0.0023608932,0.002887865,0.0014238196,0.00033942205,0.0007376719,0.0003566742],"genre_scores_gemma":[0.9973574,0.0002966102,0.000014637241,0.0003095967,0.00006828396,0.00024903452,0.0010080917,0.00009675971,0.0005995582],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99440414,0.0016536028,0.001465185,0.0011435817,0.00018507597,0.0011484134],"domain_scores_gemma":[0.9966263,0.0009238862,0.0008306632,0.0013424731,0.00020280173,0.000073883],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00030275717,0.00060692336,0.000934941,0.00096219213,0.00042186174,0.000030158815,0.0007388175,0.00035335644,0.0016976796],"category_scores_gemma":[0.0004368665,0.00063830207,0.0002932671,0.00082887296,0.0005514051,0.00023554795,0.00060330157,0.0006866635,0.0029753705],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010645698,0.00030166243,0.0059259385,0.000081318336,0.000404327,0.0007267988,0.00032693334,0.00027570725,0.9825793,0.0024651433,0.0030565192,0.002791797],"study_design_scores_gemma":[0.009193594,0.009596116,0.77998435,0.000085237036,0.0006178874,0.0047068004,0.00009871927,0.00062158576,0.15186717,0.0013412691,0.04073382,0.0011534407],"about_ca_topic_score_codex":0.000117758915,"about_ca_topic_score_gemma":0.00003421456,"teacher_disagreement_score":0.83071214,"about_ca_system_score_codex":0.000050474027,"about_ca_system_score_gemma":0.0001609828,"threshold_uncertainty_score":0.99960685},"labels":[],"label_agreement":null},{"id":"W4385448740","doi":"10.1212/nxi.0000000000200144","title":"Structural Changes of Cutaneous Immune Cells in Patients With Type 1 Diabetes and Their Relationship With Diabetic Polyneuropathy","year":2023,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Steno Diabetes Center Aarhus; Novo Nordisk Fonden; Steno Diabetes Center Copenhagen; Lundbeckfonden; Vertex Pharmaceuticals; Alnylam Pharmaceuticals","keywords":"Polyneuropathy; Diabetes mellitus; Medicine; Immune system; Type 2 diabetes; Internal medicine; Type 1 diabetes; Immunology; Endocrinology","score_opus":0.008052098084308157,"score_gpt":0.19376039136145923,"score_spread":0.18570829327715108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385448740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977961,0.00007631987,0.0000012168648,0.00096216315,0.00021801615,0.0007625386,0.000012205498,0.00013966147,0.000031777294],"genre_scores_gemma":[0.9994329,0.00006950458,0.000029899156,0.00023173551,0.00001547201,0.000024437913,0.00009880599,0.00006239067,0.000034844532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820036,0.00033445275,0.0003561018,0.00050024525,0.00016598307,0.0004428777],"domain_scores_gemma":[0.9986582,0.0004558262,0.00026363457,0.0004477907,0.000116165305,0.00005839409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010110854,0.0003142114,0.0005148574,0.00053957454,0.00010666077,0.000010810664,0.00011076964,0.00016045872,0.000009587342],"category_scores_gemma":[0.00014063784,0.00022917405,0.000032674154,0.0006886354,0.00027655612,0.000099290955,0.00008142492,0.0004592667,0.00001647357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015419332,0.00008636451,0.8456959,0.00006354182,0.00005326182,0.00023981025,0.00024578572,0.00013367513,0.15036404,0.000072545685,0.0000029980708,0.0015001383],"study_design_scores_gemma":[0.002875238,0.0077228737,0.97642845,0.0000344107,0.00007272648,0.00010833538,0.000013500955,0.0008128502,0.011646931,0.00012510418,0.000016186441,0.00014339352],"about_ca_topic_score_codex":0.0000069564467,"about_ca_topic_score_gemma":0.000013757969,"teacher_disagreement_score":0.1387171,"about_ca_system_score_codex":0.000012098366,"about_ca_system_score_gemma":0.00003971554,"threshold_uncertainty_score":0.9345447},"labels":[],"label_agreement":null},{"id":"W4387446403","doi":"10.1212/nxi.0000000000200167","title":"Increasing Neurofilament and Glial Fibrillary Acidic Protein After Treatment Discontinuation Predicts Multiple Sclerosis Disease Activity","year":2023,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Sanofi Genzyme; EMD Serono; National Institutes of Health; Genentech; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; MedDay Pharmaceuticals; Biogen; Celgene; Cure Alzheimer's Fund; U.S. Department of Defense; Sanofi; Verily Life Sciences; Bristol-Myers Squibb","keywords":"Glial fibrillary acidic protein; Multiple sclerosis; Discontinuation; Neurofilament; Disease; Medicine; Chemistry; Pathology; Internal medicine; Immunology; Immunohistochemistry","score_opus":0.04628236456953838,"score_gpt":0.2698799443217441,"score_spread":0.22359757975220573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387446403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98024255,0.00015663992,0.000010124447,0.01583235,0.0003694413,0.0026154832,0.00006215232,0.00064625597,0.000064972664],"genre_scores_gemma":[0.9964053,0.0017814409,0.0000351822,0.00034023364,0.00024488993,0.00082611025,0.00013907456,0.0000957912,0.00013199127],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9956834,0.0012172045,0.00055856764,0.0011612673,0.00050049415,0.0008790864],"domain_scores_gemma":[0.9977694,0.0007285893,0.00026123307,0.0007956313,0.00013411489,0.0003109915],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030854394,0.000522104,0.0006261665,0.0006186022,0.00043805753,0.00007287976,0.0001360517,0.00022586882,0.00004015437],"category_scores_gemma":[0.002099933,0.0004937609,0.0001890176,0.00054792967,0.0008031879,0.00042474832,0.0004516787,0.00056026276,0.00012055325],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01530459,0.00027839348,0.15776727,0.000089588895,0.000110774294,0.00073343655,0.00024415992,0.000067024455,0.78402936,0.000013484261,0.00007020264,0.04129171],"study_design_scores_gemma":[0.0040125325,0.0029579059,0.9675749,0.00007017628,0.00013505193,0.00013758484,0.000013735594,0.007835323,0.016273633,0.000017029968,0.0007270317,0.0002451171],"about_ca_topic_score_codex":0.00012198244,"about_ca_topic_score_gemma":0.00006050581,"teacher_disagreement_score":0.8098076,"about_ca_system_score_codex":0.00007743442,"about_ca_system_score_gemma":0.00014371153,"threshold_uncertainty_score":0.9997514},"labels":[],"label_agreement":null},{"id":"W4388563357","doi":"10.1212/nxi.0000000000200178","title":"Clinical Determinants of Longitudinal Disability in LGI-1-IgG Autoimmune Encephalitis","year":2023,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Genentech; Epilepsy Society; Eisai; Horizon Therapeutics; EMD Serono; National Football League Players Association; Biogen; Mylan; Cleveland Clinic; Pfizer","keywords":"Interquartile range; Medicine; Autoimmune encephalitis; Modified Rankin Scale; Internal medicine; Montreal Cognitive Assessment; Expanded Disability Status Scale; Retrospective cohort study; Encephalitis; Pediatrics; Cognitive impairment; Disease; Immunology; Multiple sclerosis","score_opus":0.04242497372743751,"score_gpt":0.3452840849990816,"score_spread":0.30285911127164405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388563357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936648,0.00015784417,0.000006119246,0.003427722,0.0009471695,0.0009924244,0.000013678842,0.00038948294,0.00040075593],"genre_scores_gemma":[0.9979967,0.001044531,0.000026321251,0.0005300397,0.000044814034,0.000084930536,0.00007289458,0.000059790553,0.00014001987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945475,0.0011205248,0.0020005244,0.0011539634,0.00034178008,0.00083571975],"domain_scores_gemma":[0.9969903,0.001062286,0.0005937705,0.0011375772,0.00011189447,0.00010415421],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067741144,0.00045035876,0.0013546835,0.00041597665,0.00013632044,0.000012623088,0.0003848976,0.00056452374,0.00013718444],"category_scores_gemma":[0.001377333,0.0004210072,0.0003988746,0.001136618,0.0014079008,0.00021729672,0.00035861673,0.0011758838,0.00026923238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015940063,0.0008853385,0.96156687,0.000071549635,0.000041195526,0.0018957206,0.000048421833,0.00008158003,0.012536931,0.00014539208,0.00005331575,0.021079695],"study_design_scores_gemma":[0.0038796067,0.003946546,0.98712623,0.000028647193,0.00008753892,0.00053762033,0.000009992386,0.0025805044,0.0005201594,0.0005853882,0.00049671106,0.00020105948],"about_ca_topic_score_codex":0.00010075743,"about_ca_topic_score_gemma":0.00005003879,"teacher_disagreement_score":0.025559371,"about_ca_system_score_codex":0.000025942962,"about_ca_system_score_gemma":0.00010427409,"threshold_uncertainty_score":0.99982417},"labels":[],"label_agreement":null},{"id":"W4389469525","doi":"10.1212/nxi.0000000000200186","title":"Defining the Clinicoradiologic Syndrome of SARS-CoV-2 Acute Necrotizing Encephalopathy","year":2023,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Encephalopathy; Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Virology; Pathology; Internal medicine; Disease; Infectious disease (medical specialty); Outbreak","score_opus":0.02417815315765875,"score_gpt":0.31242451227251894,"score_spread":0.2882463591148602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389469525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969579,0.00024511528,0.000049181843,0.025941033,0.0015689479,0.0013992945,0.000011775307,0.00082748185,0.00037820393],"genre_scores_gemma":[0.99140763,0.00044928893,0.000083840816,0.0076294043,0.000082335704,0.00011412358,0.00008254408,0.00009670822,0.000054121676],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9952797,0.0012989503,0.001190162,0.0009553079,0.00039122635,0.0008846074],"domain_scores_gemma":[0.9935318,0.00397844,0.000789275,0.0014508103,0.00017020835,0.00007945272],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009989378,0.0004882981,0.0010119335,0.00075027085,0.0003630005,0.00003209208,0.00062855496,0.00048635717,0.000018972383],"category_scores_gemma":[0.0033048415,0.00039190133,0.00037136718,0.0012704707,0.0009982183,0.00027462494,0.000457168,0.0014951465,0.00067511975],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001478641,0.0001071885,0.06791138,0.00016742646,0.0002225071,0.009169394,0.00034124654,0.00028411925,0.9134958,0.0037211876,0.00090170134,0.0021994133],"study_design_scores_gemma":[0.0025811766,0.0051489375,0.9429361,0.000055062585,0.00041363115,0.017559826,0.00001892037,0.002544854,0.025212402,0.0013570949,0.0018631311,0.00030882575],"about_ca_topic_score_codex":0.000021570295,"about_ca_topic_score_gemma":0.00000544647,"teacher_disagreement_score":0.8882834,"about_ca_system_score_codex":0.00002863799,"about_ca_system_score_gemma":0.0002283529,"threshold_uncertainty_score":0.9998533},"labels":[],"label_agreement":null},{"id":"W4390122614","doi":"10.1212/nxi.0000000000200191","title":"CNS Inflammation as the First Sign of Complement Factor I Deficiency","year":2023,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Alexion Pharmaceuticals; Sanofi","keywords":"Medicine; Complement deficiency; Eculizumab; Inflammation; Immunology; Blockade; Complement system; Complement component 5; Internal medicine; Antibody; Receptor","score_opus":0.02458383152584899,"score_gpt":0.25655512497899613,"score_spread":0.23197129345314715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390122614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98152936,0.0002607884,0.000037467453,0.0130133405,0.0021801903,0.0014568642,0.00006993613,0.00059634505,0.0008557098],"genre_scores_gemma":[0.9984668,0.00013109708,0.0000032201556,0.00057454495,0.00006771966,0.00019526716,0.0002604434,0.000056582867,0.00024430608],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99576384,0.0011690671,0.0012898415,0.00074959814,0.000191192,0.0008364601],"domain_scores_gemma":[0.996153,0.0015622594,0.0008419854,0.0011997354,0.00021201496,0.000030980325],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000463517,0.00044336324,0.0005536268,0.00059953984,0.00075415557,0.000030917603,0.0010689173,0.00029764758,0.0009443424],"category_scores_gemma":[0.00067854126,0.0003744758,0.00024038983,0.0008809215,0.00076746783,0.00022931561,0.0005352785,0.0006407513,0.0034941817],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068869535,0.0001613834,0.028981848,0.00012043286,0.00016503427,0.00007146989,0.0012000714,0.001124585,0.9444863,0.011719065,0.005941053,0.0053400453],"study_design_scores_gemma":[0.0021654705,0.0015916089,0.8664772,0.000025571298,0.000114638715,0.000370987,0.00014175665,0.00027731046,0.048642732,0.0012694877,0.07853844,0.00038483273],"about_ca_topic_score_codex":0.00007464844,"about_ca_topic_score_gemma":0.00007101551,"teacher_disagreement_score":0.89584357,"about_ca_system_score_codex":0.000028707267,"about_ca_system_score_gemma":0.000113339695,"threshold_uncertainty_score":0.99996895},"labels":[],"label_agreement":null},{"id":"W4393294855","doi":"10.1212/nxi.0000000000200217","title":"Disease-Modifying Treatments for Multiple Sclerosis Affect Measures of Cellular Immune Responses to EBNA-1 Peptides","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"European Regional Development Fund; Science Foundation Ireland","keywords":"Natalizumab; Immunology; Multiple sclerosis; Immune system; Medicine; Antigen; Epstein–Barr virus; Dimethyl fumarate; Interferon; Cellular immunity; Monoclonal antibody; Virus; Antibody; Virology","score_opus":0.1204174294013099,"score_gpt":0.32691716269160925,"score_spread":0.20649973329029936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393294855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832785,0.0020384574,0.00064485095,0.008863553,0.0008478057,0.00365244,0.00014803653,0.00045628563,0.000070059075],"genre_scores_gemma":[0.9966811,0.001106864,0.0002754826,0.00034739575,0.00017272201,0.00088282715,0.00009907434,0.00013818129,0.00029633116],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9958392,0.0007565151,0.00091648824,0.0011386683,0.00050722726,0.0008418986],"domain_scores_gemma":[0.9953948,0.0028636556,0.00019763212,0.0009683819,0.00033973073,0.00023577007],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050989847,0.0005210355,0.00089561136,0.0010799008,0.00033977214,0.000056957368,0.00034594783,0.00022179159,0.000024987421],"category_scores_gemma":[0.0051165903,0.0004821859,0.00049888087,0.0006132897,0.00044795265,0.00024000225,0.00028630844,0.0005773404,0.00009503135],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010737646,0.00022431217,0.014049992,0.00042030535,0.00040521595,0.00021625962,0.0003030743,0.00017681932,0.95289016,0.00011342235,0.00031427134,0.020148538],"study_design_scores_gemma":[0.0027618029,0.0035021994,0.82715225,0.00023301288,0.00045357103,0.00006478055,0.000020501657,0.00370181,0.15883392,0.000070227004,0.0029447044,0.00026123086],"about_ca_topic_score_codex":0.000039066017,"about_ca_topic_score_gemma":0.000012854977,"teacher_disagreement_score":0.81310225,"about_ca_system_score_codex":0.000072144416,"about_ca_system_score_gemma":0.00020742387,"threshold_uncertainty_score":0.99976295},"labels":[],"label_agreement":null},{"id":"W4394865947","doi":"10.1212/nxi.0000000000200227","title":"Trajectories of Inflammatory Markers and Post–COVID-19 Cognitive Symptoms","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; McGovern Medical School; National Institute on Aging; Georgia Clinical and Translational Science Alliance; Leonard M. Miller School of Medicine; University of Miami; York University; National Institutes of Health; Yale University; University of Texas Health Science Center at Houston; NYU Grossman School of Medicine; New York City Department of Health and Mental Hygiene","keywords":"Coronavirus disease 2019 (COVID-19); Inflammation; Cognition; Systemic inflammation; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Medicine; Immunology; Internal medicine; Virology; Psychiatry; Disease","score_opus":0.00822088208963069,"score_gpt":0.2702423323860225,"score_spread":0.26202145029639184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394865947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713096,0.0014685763,0.00014180657,0.022900227,0.0013375485,0.0015726981,0.000035402492,0.00077154714,0.00046258344],"genre_scores_gemma":[0.9919996,0.00043511862,0.000033670003,0.006889806,0.00017789428,0.000094625364,0.00009354157,0.00011732225,0.00015841563],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9961274,0.0008928944,0.0008959772,0.001096688,0.00037487558,0.0006121637],"domain_scores_gemma":[0.9938749,0.004629566,0.00030693394,0.0006291546,0.00022163606,0.00033777652],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050323096,0.0005404706,0.00078218925,0.0010678816,0.00020103517,0.000059007052,0.00024644658,0.0005182339,0.0001247834],"category_scores_gemma":[0.0051127994,0.0005338108,0.00023989164,0.000519044,0.001403727,0.00047304473,0.0002336715,0.0011797964,0.000081125036],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010665041,0.00021312923,0.13544284,0.004397412,0.00075503363,0.0080471095,0.001891477,0.00008289902,0.8167509,0.0071657,0.000661657,0.013926834],"study_design_scores_gemma":[0.0038698316,0.006165708,0.966677,0.0002057609,0.0007227939,0.0073429937,0.00006285864,0.0011754778,0.0062322193,0.000928729,0.0061459527,0.00047068213],"about_ca_topic_score_codex":0.000047140606,"about_ca_topic_score_gemma":0.000016451893,"teacher_disagreement_score":0.83123416,"about_ca_system_score_codex":0.00006374788,"about_ca_system_score_gemma":0.0007912656,"threshold_uncertainty_score":0.99971133},"labels":[],"label_agreement":null},{"id":"W4394944574","doi":"10.1212/nxi.0000000000200222","title":"Vulnerability of Thalamic Nuclei at CSF Interface During the Entire Course of Multiple Sclerosis","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Mental Health; Medical Research Council; Canadian Institutes of Health Research; National Institute of Child Health and Human Development; University of California, San Diego; University of California, Los Angeles; National Institutes of Health; Université de Bordeaux; Agence Nationale de la Recherche; National Health and Medical Research Council; Commonwealth Scientific and Industrial Research Organisation; Alzheimer's Disease Neuroimaging Initiative; Centre National de la Recherche Scientifique; National Institute on Aging; Alzheimer's Association; Ministerio de Ciencia e Innovación; Northern California Institute for Research and Education; Michael J. Fox Foundation for Parkinson's Research","keywords":"Thalamus; Atrophy; Neurodegeneration; Neuroscience; Third ventricle; Multiple sclerosis; White matter; Medicine; Magnetic resonance imaging; Pathology; Psychology; Anatomy; Radiology","score_opus":0.035575270802179836,"score_gpt":0.2925264740360285,"score_spread":0.2569512032338487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394944574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98839855,0.0011129725,0.000013185896,0.008075774,0.0008014083,0.0011040276,0.000059189737,0.0002247759,0.0002100866],"genre_scores_gemma":[0.99813396,0.0013298462,0.000015607766,0.00010947474,0.00007852055,0.000068479385,0.000018114215,0.00006978646,0.0001761852],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964113,0.0008549136,0.0009832128,0.0007809357,0.0004100344,0.0005595669],"domain_scores_gemma":[0.9965103,0.0016473898,0.0003261129,0.0011562358,0.00029176936,0.00006817411],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004511074,0.00036586996,0.0007261168,0.00031414363,0.00027659326,0.00002022936,0.00043927104,0.00023995619,0.00015917876],"category_scores_gemma":[0.0013904743,0.0002750379,0.00032716666,0.0005280581,0.0015780028,0.00020316555,0.00069495925,0.0011388948,0.000061943654],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015036719,0.00018589191,0.06134582,0.00050978,0.00020215359,0.000051335643,0.0005867941,0.00020740122,0.9296655,0.000050035505,0.00016403853,0.0055275797],"study_design_scores_gemma":[0.0011405477,0.00073330913,0.76743215,0.00008820303,0.00009846831,0.00024419915,0.000035131015,0.0038860885,0.2255126,0.000023298113,0.00070152135,0.00010446318],"about_ca_topic_score_codex":0.000045531193,"about_ca_topic_score_gemma":0.00006317159,"teacher_disagreement_score":0.70608634,"about_ca_system_score_codex":0.000062256106,"about_ca_system_score_gemma":0.00009796805,"threshold_uncertainty_score":0.9999702},"labels":[],"label_agreement":null},{"id":"W4399480087","doi":"10.1212/nxi.0000000000200272","title":"Advancing Knowledge in CNS Vasculitis","year":2024,"lang":"en","type":"editorial","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"F. Hoffmann-La Roche; Amicus Therapeutics; Teva Pharmaceutical Industries; Sanofi; AstraZeneca; Chugai Pharmaceutical; Amgen; Pfizer; GlaxoSmithKline","keywords":"Vasculitis; Neuroscience; Medicine; Psychology; Pathology; Disease","score_opus":0.005814270523213876,"score_gpt":0.26105731173517516,"score_spread":0.2552430412119613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399480087","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14426142,0.005125289,0.000012175773,0.009414078,0.8326014,0.0013820216,0.00010910015,0.00085813017,0.0062363716],"genre_scores_gemma":[0.0787169,0.028775718,0.000118063814,0.001600157,0.871949,0.00094058283,0.0058244253,0.0012843035,0.010790814],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941466,0.000795996,0.0014852062,0.0018415946,0.00053978525,0.0011908587],"domain_scores_gemma":[0.9963697,0.0014123669,0.00037762662,0.001309741,0.00034200956,0.00018855656],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00045415698,0.00090046745,0.0015138577,0.001837497,0.00020302151,0.000077799246,0.00045475777,0.003295524,0.00022823775],"category_scores_gemma":[0.0014895631,0.0009225597,0.000648184,0.0009851312,0.000430366,0.00023898581,0.00036630585,0.008504598,0.002171786],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044834323,0.00035645792,0.00018992732,0.0007655215,0.00034566628,0.009568093,0.00030470925,0.000102198755,0.010662291,0.00062035833,0.9722983,0.0043380805],"study_design_scores_gemma":[0.0033561336,0.0017212557,0.012246313,0.00044933605,0.0007303658,0.00198846,0.000013108469,0.0006017208,0.000121085985,0.0007975468,0.97740185,0.000572836],"about_ca_topic_score_codex":0.00006205827,"about_ca_topic_score_gemma":0.00021467448,"teacher_disagreement_score":0.06554453,"about_ca_system_score_codex":0.00018633237,"about_ca_system_score_gemma":0.0010284188,"threshold_uncertainty_score":0.9993225},"labels":[],"label_agreement":null},{"id":"W4399832607","doi":"10.1212/nxi.0000000000200271","title":"Cerebrospinal Fluid-In Gradient of Cortical and Deep Gray Matter Damage in Multiple Sclerosis","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sanofi Genzyme; Ministero della Salute; Multiple Sclerosis Society of Canada; Eli Lilly and Company; Bristol-Myers Squibb; Fondazione Italiana Sclerosi Multipla; Biogen; Celgene; Alexion Pharmaceuticals; Sanofi; Horizon Therapeutics; Novo Nordisk; Teva Pharmaceutical Industries","keywords":"Multiple sclerosis; Cerebrospinal fluid; Gray (unit); White matter; Neuroscience; Medicine; Pathology; Psychology; Magnetic resonance imaging; Radiology","score_opus":0.03564745854315858,"score_gpt":0.27134653822815824,"score_spread":0.23569907968499965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399832607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904563,0.0006646378,0.000022108512,0.007230137,0.0004015222,0.00086077,0.000009353458,0.00009871746,0.00025645897],"genre_scores_gemma":[0.9977348,0.0014688921,0.00006749772,0.0004843421,0.000045352317,0.00009485508,0.000020329868,0.00005398961,0.000029959485],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99671227,0.00062534626,0.0008855913,0.0008358794,0.00028399462,0.0006568973],"domain_scores_gemma":[0.9982864,0.0009582983,0.00010063491,0.00048228638,0.000077152086,0.00009520546],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035187602,0.00031991513,0.0006648769,0.0010214935,0.00008755947,0.000027311375,0.00017607932,0.00024661663,0.00010391012],"category_scores_gemma":[0.00090382167,0.00030543492,0.000109615314,0.0006202884,0.0007937272,0.00021174677,0.0002760603,0.0012892266,0.000081511454],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010650505,0.0001671261,0.42588976,0.00023308265,0.000030034635,0.0004955802,0.00034406636,0.000065021835,0.56688565,0.00019441672,0.00007782825,0.0045523583],"study_design_scores_gemma":[0.002260167,0.0011291464,0.97321755,0.00012170826,0.000036727495,0.00028474705,0.0000242522,0.017795738,0.004557465,0.00007644938,0.00034793658,0.00014814214],"about_ca_topic_score_codex":0.00011390911,"about_ca_topic_score_gemma":0.00035375703,"teacher_disagreement_score":0.5623282,"about_ca_system_score_codex":0.00004401815,"about_ca_system_score_gemma":0.000059223712,"threshold_uncertainty_score":0.9999398},"labels":[],"label_agreement":null},{"id":"W4400109826","doi":"10.1212/nxi.0000000000200269","title":"Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness <i>z</i> Scores","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; Instituto de Salud Carlos III; Chugai Pharmaceutical; Guthy-Jackson Charitable Foundation; Ipsen; Sanofi Genzyme; Stiftung Charité; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Biogen; Celgene; Alexion Pharmaceuticals; National Multiple Sclerosis Society; Horizon Therapeutics; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Bristol-Myers Squibb; Arthur Arnstein Stiftung; Eli Lilly and Company; Allergan; National Institutes of Health; Stichting MS Research; Bayer HealthCare; European Commission; Sanofi; Deutsche Forschungsgemeinschaft","keywords":"Retinal; Multiple sclerosis; Disease; Layer (electronics); Medicine; Physical medicine and rehabilitation; Gerontology; Internal medicine; Ophthalmology; Psychiatry; Materials science; Composite material","score_opus":0.057484998709608555,"score_gpt":0.2863296623488212,"score_spread":0.22884466363921263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400109826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98847866,0.00032015637,0.000053269287,0.009475443,0.00015669882,0.0012707099,0.000031564825,0.00017637994,0.000037100643],"genre_scores_gemma":[0.99891,0.0005268556,0.00010614401,0.00012911376,0.000058004593,0.00017829552,0.00003829732,0.000045842848,0.0000074070176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706155,0.0006931717,0.0004937774,0.00087269035,0.00041585095,0.0004629646],"domain_scores_gemma":[0.99738747,0.0016952024,0.00015611289,0.0005097428,0.00013354585,0.00011793503],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043966025,0.0003019164,0.00049375923,0.00035168545,0.00014366629,0.00004281995,0.00015861964,0.00016260728,0.000013809338],"category_scores_gemma":[0.0018654577,0.0002580882,0.00007347552,0.000599078,0.0015269195,0.00034757805,0.0002608103,0.0010335719,0.000006816221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072160796,0.00027375264,0.61600107,0.0005030607,0.00006107987,0.00014507711,0.00035546502,0.00008832514,0.3517836,0.0001223678,0.000011992484,0.023438111],"study_design_scores_gemma":[0.0015951297,0.0013087775,0.9844783,0.00023911966,0.00012540599,0.00011383499,0.0000167654,0.0050691795,0.0067830025,0.000056388704,0.00006554606,0.00014854176],"about_ca_topic_score_codex":0.00007770053,"about_ca_topic_score_gemma":0.00015318685,"teacher_disagreement_score":0.36847723,"about_ca_system_score_codex":0.00002941237,"about_ca_system_score_gemma":0.00013678204,"threshold_uncertainty_score":0.9999871},"labels":[],"label_agreement":null},{"id":"W4402507349","doi":"10.1212/nxi.0000000000200311","title":"IGLON5 Frequency in Idiopathic REM Sleep Behavior Disorder","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Pacific Northwest National Laboratory; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National Heart, Lung, and Blood Institute; National Center for Complementary and Integrative Health; National Institute on Aging; Alzheimer's Disease Research Center, Emory University; National Institutes of Health; Canadian Institutes of Health Research; Jazz Pharmaceuticals; Prothena; Portland VA Research Foundation; Demensförbundet; Idorsia Pharmaceuticals; National Alliance for Research on Schizophrenia and Depression; National Science Foundation; Georgia Research Alliance; Michael J. Fox Foundation for Parkinson's Research; Emory University; Biogen; Ono Pharmaceutical; U.S. Department of Defense; American Sleep Medicine Foundation; Eisai; Collins Medical Trust; National Institute of General Medical Sciences; Sunovion; American Heart Association; National Center for Advancing Translational Sciences; Teva Pharmaceutical Industries; U.S. Department of Veterans Affairs","keywords":"REM sleep behavior disorder; Parasomnia; Sleep (system call); Medicine; Audiology; Psychology; Polysomnography; Neuroscience; Psychiatry; Electroencephalography; Computer science","score_opus":0.011168504079300472,"score_gpt":0.2581972583216906,"score_spread":0.24702875424239013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402507349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792014,0.004194617,0.00008656931,0.011077176,0.0015922469,0.0013220574,0.000007932333,0.00082044676,0.0016975731],"genre_scores_gemma":[0.996301,0.0008472412,0.000036452522,0.0019989952,0.000087907625,0.00031819587,0.00007575869,0.00012082789,0.00021363929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958994,0.00057965954,0.001024763,0.001322502,0.00031746225,0.00085620716],"domain_scores_gemma":[0.99853176,0.00026012058,0.00016453986,0.0008580505,0.000075228854,0.00011027995],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023995418,0.0005700376,0.00078478706,0.0007923931,0.00017519464,0.000063961204,0.00030163993,0.00060962525,0.00021481466],"category_scores_gemma":[0.00034672912,0.0005186936,0.0002945429,0.0008992159,0.000403235,0.00034944376,0.00017679908,0.001985956,0.00068940315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017982572,0.0020497344,0.6046137,0.0003099211,0.00017192155,0.04253688,0.00039587158,0.0004599378,0.2694064,0.0061099767,0.00014687612,0.0720005],"study_design_scores_gemma":[0.002111195,0.0031930283,0.9818702,0.000048052298,0.00020886496,0.0032846085,0.000007784725,0.004205189,0.00033973609,0.0015509592,0.002882022,0.00029837035],"about_ca_topic_score_codex":0.00007262567,"about_ca_topic_score_gemma":0.000045490448,"teacher_disagreement_score":0.37725645,"about_ca_system_score_codex":0.00004869936,"about_ca_system_score_gemma":0.00012721583,"threshold_uncertainty_score":0.9997265},"labels":[],"label_agreement":null},{"id":"W4403320599","doi":"10.1212/nxi.0000000000200321","title":"Pharmacokinetics and Pharmacodynamics of Natalizumab 6-Week Dosing vs Continued 4-Week Dosing for Relapsing-Remitting Multiple Sclerosis","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"UCB Pharma; Sanofi Genzyme; EMD Serono; Genentech; Biogen; Celgene; Alexion Pharmaceuticals; Shionogi; Sanofi; Teva Pharmaceutical Industries; Bristol-Myers Squibb; Eli Lilly and Company","keywords":"Dosing; Natalizumab; Multiple sclerosis; Pharmacodynamics; Pharmacokinetics; Medicine; Relapsing remitting; Pharmacology; Immunology","score_opus":0.0320156708101307,"score_gpt":0.2740794635867067,"score_spread":0.242063792776576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403320599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866702,0.0055631404,0.00058880105,0.0033286586,0.0020670975,0.0011104194,0.00007904699,0.00043887945,0.00015378337],"genre_scores_gemma":[0.99578136,0.0024841619,0.00031456453,0.0008268326,0.0002028631,0.000047095436,0.0001155553,0.00013589312,0.00009169296],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9970386,0.0002889521,0.0009688449,0.0008526809,0.00022917877,0.00062176166],"domain_scores_gemma":[0.99761486,0.0013053389,0.0003739594,0.00038358537,0.00017891206,0.00014333772],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002778557,0.00043391003,0.0006762183,0.0005632554,0.0002903905,0.000072158065,0.0001811941,0.0003715869,0.000019405832],"category_scores_gemma":[0.000660161,0.00043671604,0.00025628525,0.00040937445,0.0005559984,0.00029570182,0.00015458431,0.00092788547,0.0000103898365],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036656505,0.00027444065,0.002652045,0.0005191366,0.00022513137,0.00026685832,0.00024713468,0.00027029432,0.9679989,0.0003348937,0.00023696193,0.023308529],"study_design_scores_gemma":[0.021931238,0.008112032,0.19354616,0.0013217654,0.003998388,0.0046293214,0.00006508,0.5350588,0.21566664,0.0005821399,0.013942085,0.0011463522],"about_ca_topic_score_codex":0.000021008793,"about_ca_topic_score_gemma":0.0000025557324,"teacher_disagreement_score":0.75233227,"about_ca_system_score_codex":0.000032384287,"about_ca_system_score_gemma":0.00013283499,"threshold_uncertainty_score":0.9998085},"labels":[],"label_agreement":null},{"id":"W4403673243","doi":"10.1212/nxi.0000000000200319","title":"Choroid Plexus Volume in Pediatric-Onset Multiple Sclerosis","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Montreal Neurological Institute and Hospital","funders":"Canadian Institutes of Health Research; Pfizer Foundation; EMD Serono; Horizon Therapeutics; National Multiple Sclerosis Society; International Progressive MS Alliance; Genentech; Epilepsy Society; Ontario Institute for Regenerative Medicine; National Institutes of Health; Myelin Repair Foundation; Kiniksa Pharmaceuticals; Shionogi; Arthritis Society; Idorsia Pharmaceuticals; Children's Hospital of Philadelphia; University of Pennsylvania; Alexion Pharmaceuticals; Pfizer; Biogen; Eli Lilly and Company; U.S. Department of Defense; Sanofi; Hospital for Sick Children; Multiple Sclerosis Society of Canada; Amgen","keywords":"Choroid plexus; Multiple sclerosis; Medicine; Volume (thermodynamics); Internal medicine; Central nervous system; Physics","score_opus":0.043185588001180206,"score_gpt":0.27797529640896884,"score_spread":0.23478970840778862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403673243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776414,0.0014049299,0.000026235566,0.016507318,0.0014858511,0.0013076124,0.000034291646,0.00079085666,0.00080149336],"genre_scores_gemma":[0.9919371,0.0057120817,0.000070788985,0.0010157905,0.00042069802,0.00024946412,0.00009543934,0.00012789817,0.00037071292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952887,0.00072686566,0.000995495,0.0013543196,0.00050715165,0.0011274634],"domain_scores_gemma":[0.99747765,0.0011424376,0.0001465457,0.0008993837,0.00016115651,0.00017285276],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045973872,0.00052348373,0.00075641833,0.0014844446,0.00022142597,0.00009020233,0.0003872976,0.0004469154,0.00021049171],"category_scores_gemma":[0.0022077414,0.0005247553,0.00025629197,0.001266933,0.0004411595,0.0004206586,0.0003867072,0.002163836,0.0011054453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023845306,0.00043701282,0.6489798,0.000483223,0.00012277937,0.0028942022,0.00054733554,0.0003281871,0.3035895,0.00014624138,0.0063171526,0.033770088],"study_design_scores_gemma":[0.002213944,0.0011960085,0.97151726,0.000045795878,0.00008827919,0.00069565966,0.000011083517,0.012098479,0.0016927023,0.000070335715,0.010090275,0.00028016925],"about_ca_topic_score_codex":0.00007887873,"about_ca_topic_score_gemma":0.00013897325,"teacher_disagreement_score":0.3225375,"about_ca_system_score_codex":0.00009162069,"about_ca_system_score_gemma":0.00022821897,"threshold_uncertainty_score":0.9997204},"labels":[],"label_agreement":null},{"id":"W4403673251","doi":"10.1212/nxi.0000000000200328","title":"Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; Sanofi Genzyme; Mitsubishi Tanabe Pharma Corporation; Fondation Charcot; Univerzita Karlova v Praze; Karadeniz Teknik Üniversitesi; Eisai; Sanofi; Multiple Sclerosis International Federation; Canadian Institutes of Health Research; Fonds Wetenschappelijk Onderzoek; Murdoch University; Multiple Sclerosis Australia; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Všeobecná Fakultní Nemocnice v Praze; Biogen; Celgene; Hunter New England Local Health District; Sveučilište u Zagrebu; F. Hoffmann-La Roche; Medicinski Fakultet, Sveučilište u Zagrebu; Monash University; Alexion Pharmaceuticals; Vlaamse regering; National Multiple Sclerosis Society; Amicus Therapeutics; Medical Research Council; Teva Pharmaceutical Industries; Novartis Pharma; European Commission","keywords":"Ocrelizumab; Medicine; Disease; Multiple sclerosis; Pregnancy; Internal medicine; Immunology; Rituximab","score_opus":0.04454560062272642,"score_gpt":0.2798303811565144,"score_spread":0.23528478053378796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403673251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97932833,0.0016505019,0.000034404133,0.016692987,0.00027414545,0.0014922296,0.000037301885,0.00043170623,0.00005839701],"genre_scores_gemma":[0.9931541,0.005248492,0.000037938422,0.0006685093,0.00009378607,0.0005275646,0.000011641655,0.00012398425,0.00013400332],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99624443,0.0007466749,0.00046180785,0.0012043382,0.00039668276,0.00094606506],"domain_scores_gemma":[0.9974853,0.0012883415,0.00013093637,0.0006935761,0.000094870804,0.00030699617],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002912134,0.0004908724,0.0006117688,0.00067646767,0.0002807325,0.00011533914,0.00019952982,0.00015161623,0.000080487065],"category_scores_gemma":[0.0011916867,0.00036907624,0.00007830577,0.0005702291,0.00070095324,0.0005168367,0.00027655458,0.0010968316,0.000030648982],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.097614236,0.00071928714,0.36600184,0.0016895524,0.0004234945,0.0049293116,0.00331519,0.00026184306,0.43582034,0.00014508315,0.000109243876,0.08897058],"study_design_scores_gemma":[0.0028315966,0.0019518393,0.98286444,0.00053740735,0.00006664871,0.00014474175,0.000042315645,0.009503207,0.0005414764,0.00006233784,0.0011768107,0.00027716198],"about_ca_topic_score_codex":0.000054727017,"about_ca_topic_score_gemma":0.00013285587,"teacher_disagreement_score":0.61686265,"about_ca_system_score_codex":0.00010119993,"about_ca_system_score_gemma":0.0002779325,"threshold_uncertainty_score":0.99987614},"labels":[],"label_agreement":null},{"id":"W4405519437","doi":"10.1212/nxi.0000000000200357","title":"Clinical Characterization and Prognostic Risk Factors of Susac Syndrome","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Retinal and Optic Conditions","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.015265332823995956,"score_gpt":0.2775201621488703,"score_spread":0.2622548293248744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405519437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946213,0.00016338169,0.00025776098,0.0029952861,0.0010138291,0.00055669027,0.000031462292,0.00023901607,0.0001212846],"genre_scores_gemma":[0.9983704,0.0009405898,0.000032614,0.00017253622,0.000068467394,0.000017671773,0.00016970813,0.000038034166,0.00018994053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978811,0.00042140522,0.0007536338,0.00054496067,0.00014462633,0.00025426963],"domain_scores_gemma":[0.99835837,0.00089633034,0.00023425606,0.0003344943,0.00009499304,0.00008154663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023907183,0.00021947086,0.0004666702,0.00035355883,0.000101429425,0.000024390938,0.00009117456,0.00025895654,0.00007873948],"category_scores_gemma":[0.00074792164,0.00019303896,0.00014617515,0.00030217879,0.0004695686,0.00018362633,0.0000807762,0.0008345033,0.000049615144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036801244,0.00017814404,0.771586,0.00023829273,0.00015703666,0.001108816,0.00015503335,0.0000073691467,0.20843068,0.0017841582,0.0000342211,0.015952218],"study_design_scores_gemma":[0.00046851792,0.002721259,0.98867977,0.0000432763,0.00032503455,0.0028105832,0.0000050939652,0.0023614306,0.000543432,0.00022811028,0.0017086042,0.00010486311],"about_ca_topic_score_codex":0.00000836901,"about_ca_topic_score_gemma":0.0000014724372,"teacher_disagreement_score":0.21709378,"about_ca_system_score_codex":0.000006145514,"about_ca_system_score_gemma":0.00008094694,"threshold_uncertainty_score":0.78719},"labels":[],"label_agreement":null},{"id":"W4409916110","doi":"10.1212/nxi.0000000000200404","title":"Extracellular Vesicle Marker Changes Associated With Disease Activity in Relapsing-Remitting Multiple Sclerosis","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Relapsing remitting; Multiple sclerosis; Extracellular vesicles; Extracellular; Extracellular vesicle; Disease; Medicine; Neuroscience; Immunology; Chemistry; Biology; Pathology; Microvesicles; Cell biology; Biochemistry","score_opus":0.012887176617179853,"score_gpt":0.21499011309462368,"score_spread":0.20210293647744382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409916110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298334,0.0014286974,0.0004323419,0.0035454656,0.00046012795,0.0007197688,0.000016412547,0.00013331245,0.00028052344],"genre_scores_gemma":[0.99794567,0.00023795867,0.00005058256,0.0007638822,0.00006189296,0.00012069237,0.00012293951,0.00007928885,0.00061711896],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963005,0.0011668982,0.00046394658,0.0011527436,0.00020292887,0.0007129478],"domain_scores_gemma":[0.99808633,0.00031263838,0.0003545013,0.001009863,0.00011982049,0.00011682572],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044353685,0.00044276327,0.00037148912,0.0003538142,0.00025768214,0.00004882855,0.0004735718,0.00040374382,0.000014848853],"category_scores_gemma":[0.0017545591,0.00048717138,0.00011714536,0.00054155843,0.0004382905,0.000035550493,0.0003271823,0.00071006943,0.0000137221],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029244283,0.0003036049,0.13272095,0.00002913977,0.000056397326,0.0001910401,0.000019518042,0.0007984556,0.8598356,0.00012456554,0.00011433512,0.0028819547],"study_design_scores_gemma":[0.0027331687,0.0006016171,0.9201167,0.000082342536,0.00008507447,0.000021283433,0.000009006932,0.0034087943,0.0712054,0.00012056175,0.0012499253,0.00036608722],"about_ca_topic_score_codex":0.000016510832,"about_ca_topic_score_gemma":0.00023169842,"teacher_disagreement_score":0.7886302,"about_ca_system_score_codex":0.000043838016,"about_ca_system_score_gemma":0.00017152244,"threshold_uncertainty_score":0.999758},"labels":[],"label_agreement":null},{"id":"W4410141120","doi":"10.1212/nxi.0000000000200403","title":"Identification of Distinct Biological Groups of Patients With Cryptogenic NORSE via Inflammatory Profiling","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Otitis Media and Relapsing Polychondritis","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute on Aging","keywords":"Identification (biology); Profiling (computer programming); Computational biology; Biology; Medicine; Computer science; Ecology","score_opus":0.0055203699811649356,"score_gpt":0.22131881555901844,"score_spread":0.21579844557785352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410141120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944313,0.0001234953,0.00061955437,0.0008458502,0.0027460703,0.0009632035,0.000014917814,0.00011819736,0.00013739435],"genre_scores_gemma":[0.9993019,0.00008613607,0.00009765178,0.00017433583,0.00003881606,0.000039806044,0.00013150959,0.000032618835,0.000097222095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973095,0.00038468762,0.0011634638,0.00055668724,0.0002443365,0.00034132073],"domain_scores_gemma":[0.99781966,0.0003189723,0.00077189447,0.0006544864,0.00038006305,0.00005490562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018039423,0.00028099588,0.000630755,0.0005526291,0.00010758018,0.000007107681,0.00023146304,0.0003719498,0.000023089442],"category_scores_gemma":[0.0005451553,0.0002394049,0.00014740315,0.0005112403,0.0008711913,0.00012882327,0.00010684766,0.0006076411,0.00001543262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015895029,0.00028077766,0.5269188,0.0001456831,0.00007106284,0.000037332276,0.000044449433,0.000019840716,0.4687229,0.0007775913,0.000025463396,0.001366533],"study_design_scores_gemma":[0.00278141,0.0014064995,0.9272265,0.000048565555,0.0001721362,0.000078254125,0.0000057715615,0.0002068226,0.06747959,0.00027707472,0.00019271507,0.00012468807],"about_ca_topic_score_codex":0.000004205452,"about_ca_topic_score_gemma":0.0000052905666,"teacher_disagreement_score":0.40124333,"about_ca_system_score_codex":0.000018964807,"about_ca_system_score_gemma":0.0001257898,"threshold_uncertainty_score":0.97626483},"labels":[],"label_agreement":null},{"id":"W4410849524","doi":"10.1212/nxi.0000000000200413","title":"Bruton Tyrosine Kinase in Lesions of Multiple Sclerosis and 3 of Its Models","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; University of Saskatchewan; University of Calgary","funders":"","keywords":"Bruton's tyrosine kinase; Tyrosine kinase; Multiple sclerosis; Medicine; Neuroscience; Biology; Internal medicine; Immunology; Receptor","score_opus":0.039710728306211446,"score_gpt":0.27725753091143246,"score_spread":0.237546802605221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410849524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943481,0.0010247085,0.000060668302,0.002896431,0.00019446624,0.0008277398,0.000010774032,0.000049225597,0.0005878941],"genre_scores_gemma":[0.99791807,0.0014919617,0.00005985204,0.00030268522,0.000012702009,0.000034816218,0.000014768564,0.000027503485,0.00013765162],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976712,0.00037183982,0.0008340068,0.00052635616,0.00021018465,0.00038640655],"domain_scores_gemma":[0.99804425,0.00083280244,0.0002447421,0.0006143887,0.00020955665,0.00005426381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026258954,0.00022128885,0.00064213446,0.00091574487,0.0000590907,0.0000053265444,0.00020524496,0.0003007639,0.000015568865],"category_scores_gemma":[0.0010656592,0.00022808039,0.00008881392,0.0007100808,0.0005295105,0.00016561888,0.00028552636,0.0005699054,0.0000052050823],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023728146,0.00027150058,0.0102277035,0.00040412287,0.000036706744,0.0001694729,0.000133069,0.0014901067,0.9780628,0.0030189732,0.000051111667,0.0037616077],"study_design_scores_gemma":[0.018638164,0.0014547284,0.63187873,0.00024632335,0.00010381074,0.00035681718,0.000017425458,0.12538394,0.2208961,0.0006938547,0.00017825706,0.00015182751],"about_ca_topic_score_codex":0.00018702698,"about_ca_topic_score_gemma":0.000059853337,"teacher_disagreement_score":0.75716674,"about_ca_system_score_codex":0.00018222826,"about_ca_system_score_gemma":0.0009293479,"threshold_uncertainty_score":0.9300849},"labels":[],"label_agreement":null},{"id":"W4411985508","doi":"10.1212/nxi.0000000000200426","title":"Peripheral HLA-DR <sup>hi</sup> CD141 <sup>+</sup> Classical Monocytes Predict Relapse Risk and Worsening in Multiple Sclerosis","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Multiple sclerosis; Physics; Human leukocyte antigen; Peripheral; Medicine; Immunology; Internal medicine; Antigen","score_opus":0.03308957877647927,"score_gpt":0.2663902908932061,"score_spread":0.23330071211672682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411985508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97862154,0.0008471955,0.00011198592,0.016996073,0.0003591399,0.0019589001,0.00004090738,0.0005258772,0.00053840375],"genre_scores_gemma":[0.99150294,0.0053310674,0.00025937898,0.001617623,0.00021745384,0.00036575217,0.00007695489,0.00012066035,0.00050815055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9922397,0.002230594,0.0015157333,0.0018959,0.0006021068,0.0015159606],"domain_scores_gemma":[0.9948726,0.0029141216,0.00040330473,0.0012769438,0.00028109946,0.00025189915],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007691746,0.00084604707,0.0013990299,0.0014575926,0.00078050833,0.00011936088,0.0005679103,0.0007886784,0.00007393231],"category_scores_gemma":[0.0076753,0.0008534522,0.00029225845,0.0012066225,0.0016385891,0.00051553507,0.0010132028,0.0036605624,0.00006734985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009672205,0.00074445043,0.7898846,0.0002899236,0.0004155956,0.0007876741,0.0020785953,0.020697156,0.110862486,0.00031433676,0.00241861,0.061834313],"study_design_scores_gemma":[0.007651091,0.0014191049,0.77102554,0.00013580258,0.00016732747,0.0002063941,0.00015868864,0.21219857,0.0011933832,0.0001218956,0.005387343,0.00033486186],"about_ca_topic_score_codex":0.00019210263,"about_ca_topic_score_gemma":0.00013289838,"teacher_disagreement_score":0.19150142,"about_ca_system_score_codex":0.00015522767,"about_ca_system_score_gemma":0.00023738963,"threshold_uncertainty_score":0.9993916},"labels":[],"label_agreement":null},{"id":"W4412796828","doi":"10.1212/nxi.0000000000200450","title":"Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Neuromyelitis optica; Extension (predicate logic); Spectrum disorder; Term (time); Open label; Medicine; Broad spectrum; Spectrum (functional analysis); Dermatology; Internal medicine; Psychiatry; Computer science; Multiple sclerosis; Adverse effect; Physics; Chemistry","score_opus":0.022535761892066714,"score_gpt":0.2970093437663452,"score_spread":0.2744735818742785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412796828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98309004,0.00020132089,0.000016021457,0.011516374,0.0002682258,0.0047062836,0.000021801405,0.00006491007,0.000115047704],"genre_scores_gemma":[0.9985126,0.0005138211,0.000027912147,0.0006808802,0.000026596223,0.00008914106,0.00007231472,0.000046496934,0.000030199377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99593735,0.0011950651,0.00088887016,0.0010417781,0.00037900134,0.0005579197],"domain_scores_gemma":[0.99662876,0.0016114425,0.0003075758,0.0011978379,0.00018911247,0.00006524744],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027047697,0.00042053882,0.00087355863,0.00035847773,0.0003026132,0.000052514926,0.0005741578,0.00016849971,0.000029438568],"category_scores_gemma":[0.0011619827,0.0002996374,0.000045008645,0.00065498333,0.00074862665,0.00023732637,0.0010094742,0.0010453728,0.000007586808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01928083,0.001973955,0.9488413,0.000037504637,0.00016172398,0.00013890896,0.00027304736,0.00004387433,0.00868413,0.00007826824,0.000030408184,0.020456087],"study_design_scores_gemma":[0.029161341,0.006578636,0.96338075,0.00009299872,0.00015762134,0.000019951915,0.000024504707,0.00015260765,0.00016314157,0.000039114042,0.00007409474,0.00015525613],"about_ca_topic_score_codex":0.00032522788,"about_ca_topic_score_gemma":0.0006161454,"teacher_disagreement_score":0.02030083,"about_ca_system_score_codex":0.000032774504,"about_ca_system_score_gemma":0.000104713276,"threshold_uncertainty_score":0.9999456},"labels":[],"label_agreement":null},{"id":"W4412984063","doi":"10.1212/nxi.0000000000200457","title":"Serum Levels of Aryl Hydrocarbon Receptor Plasma Agonist Activity Are Reduced in Patients With NMOSD and Correlate With Disease Activity","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Toxic Organic Pollutants Impact","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Aryl hydrocarbon receptor; Agonist; Hydrocarbon; Disease; Aryl; Receptor; Chemistry; Medicine; Internal medicine; Pharmacology; Organic chemistry; Biochemistry","score_opus":0.005072107767123717,"score_gpt":0.19303847935466703,"score_spread":0.1879663715875433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412984063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956749,0.0000074882705,0.000020436673,0.0028621445,0.00028766086,0.0007754167,0.000096825046,0.000095511125,0.00017959873],"genre_scores_gemma":[0.9995941,0.000016256741,0.000015369686,0.00023434914,0.00000759385,0.000014890304,0.0000022662796,0.000044613047,0.000070559094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975261,0.00037657982,0.00037155708,0.0008890465,0.0002867715,0.00054991944],"domain_scores_gemma":[0.99839175,0.00025810645,0.00053282036,0.0006932297,0.000010429392,0.000113686496],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013374523,0.0004075543,0.00049814995,0.00023694558,0.00017056099,0.0000225501,0.00031606978,0.00021900088,0.0000891593],"category_scores_gemma":[0.00024256698,0.00036551247,0.000040841718,0.00064271694,0.0009051948,0.0005223997,0.00029749886,0.0008054366,0.00002191758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008794245,0.0003274156,0.60272497,0.000025220204,0.000039600895,0.00008235902,0.00012446141,0.0006838479,0.36321148,0.000012255567,0.000010595422,0.023963524],"study_design_scores_gemma":[0.0029921138,0.0012634777,0.979167,0.000029977115,0.000054992615,0.000020223666,0.000003916811,0.0014021485,0.014754377,0.000048473572,0.00002700675,0.00023631948],"about_ca_topic_score_codex":0.000038340393,"about_ca_topic_score_gemma":0.00016346238,"teacher_disagreement_score":0.376442,"about_ca_system_score_codex":0.000089962195,"about_ca_system_score_gemma":0.00008565185,"threshold_uncertainty_score":0.99987966},"labels":[],"label_agreement":null},{"id":"W4415200142","doi":"10.1212/nxi.0000000000200499","title":"Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Deutsche Forschungsgemeinschaft","keywords":"Multiple sclerosis; Intrathecal; Immune system; Disease; Antibody; Genotype; Allele; Gene; Genetic variants","score_opus":0.03524138278745751,"score_gpt":0.2808802101617838,"score_spread":0.24563882737432632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415200142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809771,0.000311709,0.0015611796,0.01321178,0.00050969986,0.0028340959,0.000098030614,0.00026199187,0.00023442392],"genre_scores_gemma":[0.9921901,0.0011151124,0.0015807227,0.0039027596,0.00014884342,0.00085010374,0.000011839338,0.00008414626,0.00011637398],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9961853,0.00074472604,0.0008497356,0.0011361906,0.00023943129,0.000844614],"domain_scores_gemma":[0.99564224,0.0027571626,0.00025039652,0.0009120751,0.00028030117,0.00015779484],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042101054,0.00046537982,0.0008160893,0.00068674714,0.0005479312,0.000058743015,0.0003524426,0.00040442625,0.00004305471],"category_scores_gemma":[0.008775448,0.00045701384,0.0001894175,0.0005260828,0.00051197223,0.00010421912,0.00040997946,0.0008279721,0.00007644774],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070991633,0.0002847868,0.100518934,0.00015600369,0.00038637672,0.00004669257,0.00026388187,0.0002299935,0.7812371,0.00023052763,0.0011879301,0.10835856],"study_design_scores_gemma":[0.0034980078,0.0013471289,0.97350156,0.00005611359,0.00026284554,0.00009070684,0.000018994195,0.005243849,0.0063958354,0.0001715897,0.00917715,0.00023622856],"about_ca_topic_score_codex":0.00011256726,"about_ca_topic_score_gemma":0.00007899516,"teacher_disagreement_score":0.8729826,"about_ca_system_score_codex":0.00004603875,"about_ca_system_score_gemma":0.00012322485,"threshold_uncertainty_score":0.99978817},"labels":[],"label_agreement":null},{"id":"W4416328073","doi":"10.1212/nxi.0000000000200449","title":"Spinal Cord Leptomeningeal Enhancement as a Marker of Extensive Spinal Cord Involvement in Children With MOGAD","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Hereditary Neurological Disorders","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Ottawa Hospital; Montreal Neurological Institute and Hospital; Dalhousie University; University of Ottawa","funders":"","keywords":"Spinal cord; Cord; Central nervous system disease; Central nervous system; Lesion","score_opus":0.01927620104970906,"score_gpt":0.2810440360805897,"score_spread":0.26176783503088064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416328073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891202,0.00012311924,0.00017783402,0.0061371587,0.0008238787,0.0019715952,0.000010695779,0.00020739812,0.0014281255],"genre_scores_gemma":[0.99094504,0.00031834,0.00006313947,0.008192827,0.000041632324,0.0002221842,0.000017755048,0.000060591075,0.00013846198],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9935193,0.0015576546,0.0013348509,0.0018745292,0.00058658887,0.0011270873],"domain_scores_gemma":[0.9974957,0.00045903918,0.0006959741,0.0010617466,0.00017419725,0.00011333194],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003232286,0.000707319,0.00088709104,0.001124042,0.00024667563,0.00004254128,0.0010322914,0.00037963092,0.0001567262],"category_scores_gemma":[0.0012066973,0.0006867827,0.00016645387,0.0015190399,0.0012735036,0.0004092774,0.00055007247,0.0015503047,0.00012372626],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047142733,0.0008870206,0.074227095,0.00007164839,0.00007504888,0.00087658333,0.000059560753,0.0004559917,0.85194385,0.003470776,0.00018849682,0.020601185],"study_design_scores_gemma":[0.0038502568,0.03662571,0.87879133,0.000059612987,0.00007912539,0.0006478154,0.000024360432,0.0005318522,0.07647554,0.0015421311,0.0009116261,0.00046064498],"about_ca_topic_score_codex":0.00011252169,"about_ca_topic_score_gemma":0.00005275657,"teacher_disagreement_score":0.80456424,"about_ca_system_score_codex":0.000058708665,"about_ca_system_score_gemma":0.00026007966,"threshold_uncertainty_score":0.9995583},"labels":[],"label_agreement":null},{"id":"W7116829828","doi":"10.1212/nxi.0000000000200532","title":"Sex Bias in IL-10 Production by Type I Regulatory T Cells Regulated by PI3K/mTOR Signaling","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche","keywords":"Production (economics); Signal transduction; Production model; Expression (computer science)","score_opus":0.012773080467835582,"score_gpt":0.2258044764728503,"score_spread":0.2130313960050147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116829828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97943014,0.0057151406,0.000025923515,0.0055786828,0.006559708,0.0012484271,0.00002918491,0.00044000783,0.0009728038],"genre_scores_gemma":[0.97511023,0.00027656934,0.000010100314,0.000657528,0.00007220998,0.00009350274,0.0003668189,0.00007926935,0.023333788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9927611,0.003079916,0.0013102483,0.0018167753,0.000112091904,0.0009199009],"domain_scores_gemma":[0.9970207,0.0004769248,0.0006126641,0.0015905675,0.0002648295,0.00003429748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008554766,0.0006271882,0.00087671744,0.0007351648,0.00039112617,0.000037916434,0.0007517532,0.0010282578,0.00029230703],"category_scores_gemma":[0.0010341072,0.0006718649,0.00014891922,0.0010725779,0.0006672028,0.0003691823,0.00029760043,0.0013835524,0.0006774525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073617464,0.00020156713,0.004914983,0.000056625562,0.000106694955,0.00002988101,0.00014260538,0.00017537315,0.9318903,0.00013929533,0.059462816,0.0021436692],"study_design_scores_gemma":[0.0018948406,0.00088202127,0.035504635,0.00006647587,0.00007854142,0.00023030664,0.000032565462,0.00002538845,0.88459,0.00040153522,0.075825565,0.00046808302],"about_ca_topic_score_codex":0.000055525223,"about_ca_topic_score_gemma":0.0000114791255,"teacher_disagreement_score":0.04730027,"about_ca_system_score_codex":0.00007024196,"about_ca_system_score_gemma":0.0001585227,"threshold_uncertainty_score":0.99957323},"labels":[],"label_agreement":null},{"id":"W7116887376","doi":"10.1212/nxi.0000000000200534","title":"Enterovirus Encephalitis in People With Multiple Sclerosis on Ocrelizumab","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Viral Infections and Immunology Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women and Children’s Health Research Institute; University of Alberta; University of Saskatchewan","funders":"","keywords":"Ocrelizumab; Encephalitis; Hypogammaglobulinemia; Enterovirus; Multiple sclerosis; Complication; Viral disease","score_opus":0.020060701755528376,"score_gpt":0.2616693950316127,"score_spread":0.2416086932760843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116887376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98125345,0.00017918681,0.000075677104,0.01187672,0.00055411365,0.00097604084,0.0000053027416,0.00022780754,0.0048516835],"genre_scores_gemma":[0.99445343,0.00051604793,0.000027092212,0.004136935,0.000031873817,0.00020366,0.000029734078,0.000042367406,0.00055885053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971092,0.0005927137,0.0005829582,0.00082736096,0.00020360979,0.00068415917],"domain_scores_gemma":[0.99827766,0.0005426181,0.0001448156,0.00083208695,0.00014846248,0.000054339645],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019379493,0.00036260107,0.0006049555,0.0013137091,0.00025303647,0.000034859295,0.0002550533,0.00035787062,0.000087179455],"category_scores_gemma":[0.0005157732,0.00032004854,0.00011926769,0.0011326222,0.00046435013,0.00020750325,0.00014871945,0.0015628008,0.00019872733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010402582,0.0008232932,0.65914845,0.00006289831,0.00012763223,0.00058211817,0.000120946075,0.00030580207,0.31171215,0.001844658,0.00034995785,0.014519522],"study_design_scores_gemma":[0.005565584,0.0052587753,0.9733191,0.00008176975,0.000042133874,0.00045444115,0.00001816382,0.00082908926,0.009883411,0.00008788799,0.004294653,0.00016498286],"about_ca_topic_score_codex":0.0002077052,"about_ca_topic_score_gemma":0.00031165377,"teacher_disagreement_score":0.31417066,"about_ca_system_score_codex":0.000078487974,"about_ca_system_score_gemma":0.00018467459,"threshold_uncertainty_score":0.99992514},"labels":[],"label_agreement":null}]}